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Abstract 
Viral double-stranded RNA (dsRNA) molecules are a potent pathogen-associated 
molecular pattern and play a crucial role in the innate immune response. During a viral 
infection, extracellular and intracellular dsRNA can initiate pathways resulting in the 
production of type I interferons (IFNs) and interferon-stimulated genes (ISGs). The 
accumulation of ISGs within a cell results in a protective antiviral state.  This study used 
both commercially available dsRNA (poly I:C) and in vitro transcribed dsRNA 
molecules, based on the viral hemorrhagic septicemia virus (VHSV) genome sequence, as 
stimuli to investigate the effects of these molecules on the innate immune response in 
rainbow trout cells.  The goals of the present project were to elucidate the i) IFN ii) ISG 
and iii) antiviral responses of fish cells to both types of dsRNA molecules. Different 
lengths of poly I:C and in vitro transcribed dsRNA were used to determine potential 
length effects of dsRNA in fish cells. The aims of the project were achieved using a 
functional interferon assay, an ISG-promoter reporter system, an antiviral assay, and RT-
PCR.  It was found that extracellular dsRNA, either poly I:C or in vitro transcribed 
dsRNA, is able to induce innate antiviral responses in the fish cell line, RTG-2.  
Consistent with mammalian studies there was a greater magnitude of immune response 
when cells were stimulated with longer dsRNA molecules, demonstrating dsRNA length 
effects in fish cells.   
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CHAPTER 1: INTRODUCTION 
1.1 Double Stranded (ds)RNA 
 Double-stranded RNA (ds)RNA was first identified in 1963 in 
encephalomyocarditis-infected mouse ascites tumor cells (Montagnier and Sanders, 
1963).  The dsRNA structure has since been elucidated; dsRNA is comprised of two 
antiparallel strands in a right-handed double helix (DeWitte-Orr and Mossman, 2010).  
dsRNA has a 11-fold helical pitch and exhibits Watson-Crick base pairing (Tang and 
Draper, 1994).  dsRNA has an A-helix motif and a narrow, deep major groove, and a 
shallow minor groove.  The diameter of dsRNA is 30% larger than DNA, and the net 
charge of dsRNA is lower than DNA (Gast and Sanger, 1994; Van Den Hout et al., 
2010).   The molar absorbance coefficient of dsRNA is lower than ssRNA and the 
melting temperature of dsRNA is higher than ssRNA or DNA (Libonati et al., 1980).  
DsRNA is stable in the extracellular space because of its high melting temperature and 
resistance to nuclease degradation.  dsRNA is not digested by RNase A and B, or by 
RNase T1 under high salt conditions, but is digested by RNase III (Libonati et al., 1980; 
DeWitte-Orr and Mossman, 2010). 
1.1.1 Viral DsRNA 
All viruses produce dsRNA at some point in their replication cycle (Jacobs and 
Langland, 1996).  This includes viruses of all genome types; dsRNA is produced as a 
replicative intermediate from ssRNA viruses, genomic fragments from dsRNA viruses, 
and by overlapping convergent transcripts from DNA viruses (Jacobs and Langland, 
1996).  The dsRNA molecules produced by a viral infection are referred to as native 
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dsRNA. As dsRNA is a byproduct of replication, the length of the viral genome appears 
to correlate with the size of the dsRNA molecules produced; larger genomes have the 
capacity to generate larger dsRNA molecules (DeWitte-Orr et al., 2009). 
dsRNA is an effective signaling molecule for a number of reasons.  As mentioned 
above it is resistant to nuclease degradation and as such is stable in the extracellular space 
(Takeuchi and Akira, 2009). It is also a potent signaling molecule; a single long dsRNA 
molecule within a cell is sufficient to induce a response (Marcus and Sekellick, 1977).  
Host cells in vertebrates do not produce endogenous dsRNA greater than ~30bp in length 
whereas viruses produce longer molecules (DeWitte-Orr and Mossman, 2010).  This 
difference allows the immune system to discriminate self- and viral-dsRNA molecules 
(DeWitte-Orr and Mossman, 2010).  Cells use endogenous dsRNA molecules in the 
RNAi pathway (Novina and Sharp, 2004).  When an infected cell lyses the viral dsRNA 
is released into the extracellular space (Figure 1.1).  These molecules can be recognized 
and brought into neighbouring cells by surface expressed class-A scavenger receptors 
(SR-As) through clathrin-mediated endocytosis (DeWitte-Orr et al., 2010).  Viral dsRNA 
in the endosome activates endosomal dsRNA receptors; subsequently, dsRNA appears to 
escape the endosome by an undetermined mechanism, activating cytoplasmic receptors as 
well (Figure 1.1) (DeWitte-Orr et al., 2010).  
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Figure 1.1 Viral dsRNA initiated antiviral pathways.    
Extracellular viral dsRNA is recognized by scavenger receptors or TLR22, both located 
on the cell membrane.  TLR22 recruits TICAM-1 and initiates ISG and interferon 
synthesis through IRF3 and IRF7.  SR-As internalize the dsRNA through clathrin-
mediated endocytosis, where dsRNA either remains in the endosome or escapes into the 
cytoplasm.  Viral replication also results in cytoplasmic dsRNA.  Endosomal dsRNA is 
recognized by TLR3, which recruits TICAM-1 and through IRF3/7 induces expression of 
IFNs and ISGs.  Cytoplasmic dsRNA is recognized by multiple PRRs including the RLR 
family that contains MDA5 and RIG-I and upon binding to dsRNA and activation 
subsequently activates IPS-1, IRF3, and IRF7 leading to an antiviral response.  PKR 
recognize cytoplasmic viral dsRNA and activates IRF3/7 through IPS-1 or halts protein 
synthesis by phosphorylating eIF2α.          
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1.1.2 Synthetic dsRNA: Poly I:C 
It was determined in the late 1950s that polyinosinic and polycytidylic acid can 
form a helical complex with a 1:1 composition and the same ribose-phosphate backbone 
as a ribonucleic acid (Davies and Rich, 1958).  By the mid-1960s it was found that 
dsRNA molecules were potent inducers of type I interferons (IFNs) (Lampson et al., 
1967). Scientists from Merck were the first to show that polyinosinic: polycytidylic acid 
(poly I:C) could be used to induce IFNs in mammals (Carter and de Clercq, 1974), and 
now poly I:C is a commonly used viral dsRNA mimic or TLR3 agonist (Loseke et al., 
2006).  Poly I:C is a potent immunostimulant, however it lacks the natural structures, 
base composition, and sequence variations of viral dsRNA (Loseke et al., 2006).  
Because of these differences poly I:C does not accurately reflect the functional properties 
of natural dsRNA fragments (Loseke et al., 2006).  A practical example of this was seen 
in a study measuring phosphorylation of interferon-regulatory factor 3 (IRF3).  It was 
determined that the kinetics of the dsRNA-induced phospho-IRF3 expression were 
different in response to poly I:C compared to in vitro transcribed dsRNA molecules based 
on a viral genome (Jiang et al., 2011).  Poly I:C has been investigated as a therapeutic 
agent in mammals but had toxic effects due to its potency (DeWitte-Orr and Mossman, 
2010).  
High- and low- molecular weight (HMW and LMW) poly I:C are commercially 
available products.  HMW poly I:C has a range of 1.5bp-8kb fragments and LMW poly 
I:C has a range of 0.2-1kb. A previous study used HMW and LMW poly I:C to explore 
length effects within the immune response (Jiang et al., 2011).  Poly I:C is commonly 
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used in fish to study innate antiviral responses, both in vitro and in vivo (DeWitte-Orr et 
al., 2007; Congleton and Sun, 1996; Chang et al., 2011).    
1.1.3 Synthetic dsRNA: In Vitro Transcribed dsRNA 
  In vitro transcribed dsRNA can act as a viral dsRNA mimic with a sequence that 
is more biologically relevant compared to poly I:C.  The sequence of the dsRNA 
molecule can be selected by the researcher and be based on a viral genome sequence. In 
vitro transcribed dsRNA molecules represent relevant viral sequences of defined length 
which allow for exact molar amounts of dsRNA to be added to cells, the main concerns 
with poly I:C.   In vitro transcribed dsRNA is made using a T7 RNA polymerase based 
transcription system (Jiang et al., 2011).  T7 RNA polymerase is produced by the T7 
bacteriophage and is used for in vitro transcription of RNA due to its robust activity and 
promoter specificity (Sousa and Mukherjee, 2003).  Previous studies have used in vitro 
transcribed dsRNA as a native viral dsRNA alternative to study the immune response. 
Studies in mice and human cells demonstrate similar but not identical innate immune 
responses when cells were treated with poly I:C or in vitro transcribed dsRNA (DeWitte-
Orr et al., 2009; Jiang et al., 2011). These studies also utilized different lengths of in vitro 
transcribed dsRNA to look at length effects on innate immune responses (DeWitte-Orr et 
al., 2009; Jiang et al., 2011).  Although not nearly as well studied as poly I:C, there is a 
single study where a variety of lengths of in vitro transcribed dsRNA were used to study 
length requirements for fish and human dsRNA receptor activation of immune pathways 
(Matsuo et al., 2008).  
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1.2 Innate Immunity  
 dsRNA is sensed by the first line of defense against microorganism infection, the 
innate immune system (Akira et al., 2006).  Unlike the adaptive immune response that is 
specific to vertebrates, all multicellular organisms have an innate immune system 
(Medzhitov and Janeway, 1997). The innate immune system recognizes microorganisms 
through germline encoded pattern recognition receptors (PRRs) (Akira et al., 2006).  
PRRs can be humoral macromolecules in the plasma, endocytic surface-expressed 
receptors, or signaling receptors expressed intracellularly or on the cell surface 
(Medzhitov and Janeway, 1997).  PRRs share common characteristics; they are expressed 
constitutively within a host cell, are germline encoded, expressed on all cells of a given 
type, and are independent of immunological memory (Akira et al., 2006).  PRRs 
recognize pathogen-associated molecular patterns (PAMPs) (Akira et al., 2006; 
Medzhitov and Janeway, 1997).   
 PAMPs are structures that are unique to pathogens and are required for the 
survival of the microorganism producing them (Akira et al., 2006; Medzhitov and 
Janeway, 1997).  The conservation of these microbial structures between large groups of 
pathogens allows for a small number of PRRs to recognize a wide variety of PAMPs  
(Medzhitov and Janeway, 1997).  Some examples of PAMPs include bacterial 
lipopolysaccharide and flagellin, and viral nucleic acids (ssRNA, dsRNA and DNA) 
(Akira et al., 2006). 
 PAMPs have potential applications as vaccine adjuvants.  An immunological 
adjuvant is a substance used in combination with a vaccine antigen that accelerates, 
extends, or improves an antigen-specific immune response (Sasaki and Okuda, 2000).  
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Adjuvants stimulate the innate immune system to produce signals required for the 
adaptive immune response to become activated (Medzhitov and Janeway, 1997).  While 
adjuvants are potent immune response stimulators, many fail to be clinically relevant due 
to adverse side effects (Medzhitov and Janeway, 1997). Poly I:C is a potential adjuvant 
target, however it has limited clinical applications in mammals due to its potency 
(DeWitte-Orr and Mossman, 2010). The toxicity seen in mammals does not seem to be as 
robust in fish.  For example poly I:C has been used as an effective adjuvant in studies 
using Japanese flounder.  However poly I:C has appeared to have some toxic effects in 
Atlantic Salmon at certain temperatures (Takami et al., 2010; Salinas et al., 2004).  
 The PRRs involved in dsRNA sensing in fish are described below and shown in 
Figure 1.1. What is known of their subsequent signaling pathways, the resulting induction 
of IFNs, interferon-stimulated genes (ISGs) and the antiviral state, are summarized below 
for mammals and, where known, in fish. 
1.3 Pattern Recognition Receptors (PRRs)  
1.3.1 Class-A Scavenger Receptors 
There are a number of PRRs expressed by host cells, at different interfaces 
between the cell and its environment (surface, endosome, cytoplasm) that detect viral 
dsRNA. As mentioned, scavenger receptors, being surface expressed, are one of the first 
receptors to recognize dsRNA.  Scavenger receptors were initially characterized for their 
ability to bind and internalize acetylated low-density lipoproteins (acLDL) (Goldstein et 
al., 1979).  Scavenger receptors are now known to bind a wide range of polyanionic 
molecules (Limmon et al., 2008; Whelan et al., 2012).  There are 8 classes of scavenger 
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receptors (A-H) (Murphy et al., 2005).  Class-A scavenger receptors (SR-As) can bind 
and internalize dsRNA (Limmon et al., 2008; Whelan et al., 2012), delivering the dsRNA 
molecules to intracellular sensors (DeWitte-Orr et al., 2010).  SR-As in mammals 
include: SR-AI/II, MARCO, SCARA3, SCARA4 and SCARA5 (Murphy et al., 2005; 
Whelan et al., 2012). SR-As mediate dsRNA binding in murine and human fibroblasts 
(DeWitte-Orr et al., 2010). Little is known about SR-As in fish, however the SR-As 
SCARA3, SCARA4, and SCARA5 have been identified in a small number of fish species 
through a bioinformatics search (Whelan et al., 2012).  A SCARA5 homolog has been 
cloned and demonstrated to recognize and internalize LPS in Tetraodon nigroviridis 
(Meng et al., 2012).  Rainbow trout cell lines appear to express SR-As that bind dsRNA 
and acLDL, based on binding/blocking studies and transcript analysis (unpublished data).  
Once dsRNA is internalized endoplasmic and cytoplasmic PRRs are able to recognize the 
molecule.           
1.3.2 TLR3 
Toll-like receptor 3 (TLR3) is a member of the Toll-like receptor family and is an 
endosomal sensor for dsRNA. TLR3 contains extracellular domain (ECD) monomers that 
bind cooperatively to dsRNA to form TLR3ECD dimers.  Multiple dimers can bind the 
same dsRNA molecule (Leonard et al., 2008).  dsRNA binding by TLR3 requires a low 
pH such as what is found in an acidified endosome (Leonard et al., 2008). Once activated 
TLR3 recruits toll/IL-1 receptor (TIR) domain-containing adaptor molecule 
(TRIF/TICAM), which initiates downstream interferon signaling pathways through 
interferon regulatory factor 3 (IRF3) (Leonard et al., 2008; Sen and Sarkar, 2005).  TLR3 
acts through the IRF3/7 pathway to induce type I IFN and ISG production (Figure 1.1) 
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(Holland et al., 2008).  TLR3 has been identified in multiple fish species including 
rainbow trout (Rodriguez et al., 2005). 
1.3.3 TLR22 
In addition to TLR3, teleost fish express TLR22 (Matsuo et al., 2008).  TLR22 is 
a cell surface dsRNA receptor expressed only in aquatic animals (Workenhe et al., 2010). 
Both TLR3 and TLR22 use the adapter protein TRIF/TICAM-1, however their pathways 
are thought to function independently of one another (Matsuo et al., 2008). It is not 
known whether TLR22 requires a low pH for dsRNA binding, which is the case for 
TLR3. Once bound to dsRNA, TLR22 activates IRF3 to initiate the production of type 1 
IFNs (Kasamatsu, 2013).  TLR22 represents a key difference between mammalian and 
teleost fish/amphibian dsRNA mediated pathways.     
1.3.4 RIG-I/MDA5 
The retinoic acid-inducible gene I (RIG-I) – like receptors (RLRs) are a family of 
dsRNA PRRs that include RIG-I and melanoma differentiation-associated protein 5 
(MDA5), as well as Laboratory of Genetics and Physiology 2 (LGP2). LGP2 lacks a 
functional caspase-recruitment domain (CARD) and therefore is not believed to be 
involved in downstream signaling (Takeuchi and Akira, 2008).  RIG-I and MDA5 are 
helicases located in the cytoplasm of host cells (Takeuchi and Akira, 2008; Peisley and 
Hur, 2012).  In its inactivated state the CARD of RIG-I is not exposed (Jensen and 
Thomsen, 2012).  When dsRNA binds to the repressor domain of RIG-I the CARD 
domain is exposed allowing interactions with the adaptor molecule, interferon promoter 
stimulator (IPS-1), which when activated initiates IFN-mediated singling pathways via 
IRF3/7 (Figure 1.1) (Jensen and Thomsen, 2012).   
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Melanoma differentiation-associated antigen 5 (MDA5) is another member of the 
RLR family.  MDA5 is homologous to RIG-I; containing the same domain structure.  A 
main difference between RIG-I and MDA5 is MDA5 preferentially binds longer lengths 
of dsRNA (> 1000bp) and RIG-I preferentially binds shorter dsRNA (<1000 bp) (Jensen 
and Thomsen, 2012).  RIG-I has yet to be identified in rainbow trout, but RIG-I-like 
proteins have been found in carp and salmon (Biacchesi et al., 2009).  MDA5 has been 
cloned from rainbow trout (Chang et al., 2011).  Activated MDA5 induces IFN and ISG 
transcript expression via the IPS-1, IRF3/7 pathway, similar to RIG-I (Holland et al., 
2008; Yoo et al., 2008). 
1.3.5 PKR 
The dsRNA-dependent protein kinase (PKR) is a cytoplasmic PRR that functions 
as a serine/threonine protein kinase.  PKR belongs to a family of stress-response kinases, 
including PKZ, GCN2, HRI and PERK (Lemaire et al., 2008).  The PKR regulatory 
module contains an N-terminal dsRNA-binding domain that has two tandem dsRNA 
binding motifs (Lemaire et al., 2008).  dsRNA binding to PKR brings multiple PKR 
molecules into close proximity with each other allowing for dimerization, 
autophosphorylation and subsequent PKR activation (Lemaire et al., 2008). When active, 
PKR phosphorylates the eukaryotic initiation factor eIF2α resulting in global inhibition 
of protein synthesis by sequestering a component of the translation machinery (Garner et 
al., 2003; Balachandran et al., 2000). PKR is constitutively expressed in human and 
murine cells in an inactive form (Balachandran et al., 2000).  PKR-like genes have been 
characterized in fish, and PKR activity, particularly eIF2α phosphorylation, has been 
found in rainbow trout (Garner et al., 2003).  
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1.3.6 OAS/RNase L System 
Another cytoplasmic PRR involved in dsRNA binding in mammals is 
oligoadenylate synthetase (OAS).   OAS expression is IFN sensitive and is upregulated in 
response to IFN treatment via the interferon sensitive response element (ISRE) within its 
promoter region (Silverman, 2007).  OAS binds cytoplasmic dsRNA and is activated 
resulting in the production of 2-5 adenylates (2-5A) species from ATP (Silverman, 2007).  
These 2-5A molecules bind and activate the nuclease RNase L (Silverman, 2007).  
RNaseL degrades ssRNA molecules, including both host and viral mRNAs, effectively 
blocking protein translation in the cell (Silverman, 2007).  In humans three OAS genes 
have been identified that encode for 8-10 different isoforms of OAS and in mice eight 
OAS1 genes have been identified (Silverman, 2007).  
1.3.7 Length Dependence 
dsRNA length appears to be a major influencer of immune response. In addition 
to meeting the minimal length required by each PRR for binding dsRNA (usually >30bp), 
long dsRNA molecules (1000-3000bp) have been shown to induce higher levels of IFN 
and ISGs in murine fibroblasts compared with shorter molecules (200-500bp) (DeWitte-
Orr et al., 2009; Kato et al., 2008).  Length effects of dsRNA on immune responses have 
been previously demonstrated in a number of mammalian species; however to our 
knowledge the present study is the first investigating the effects of different dsRNA 
lengths in fish cells.  A study done in rabbits found that dsRNA of 661bp in length 
induced more potent acute-phase effects when compared to a 108bp molecule (Fang et 
al., 1999).  A human cell line (HUH7.5/RIG-I) with an ISG56 promoter reporter assay 
showed a significantly greater response to longer dsRNA (Binder et al., 2011).  A study 
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done in murine embryonic fibroblast cells demonstrated that longer dsRNA molecules 
induced a greater magnitude of antiviral, ISG, and interferon response (DeWitte-Orr et 
al., 2009).  There is a single report with TLR22 (a fish receptor) being expressed in 
human cells that showed length effects, suggesting that longer dsRNA molecules might 
also be more potent in fish as is observed in mammals (Matsuo et al., 2008).  
Length effects can be explained by the mechanisms by which PRRs are able to 
induce immune responses. Firstly, length dictates whether a PRR can bind a dsRNA 
molecule. RIG-I and MDA5 both are able to bind to dsRNA molecules of approximately 
18bp in length, they require longer lengths for activation, 30bp for RIG-I and up to 
2000bp for MDA5 (Berke and Modis, 2012).  RIG-I recognizes short dsRNA strands 
(<1000bp) and MDA5 recognizes longer strands (>1000bp) (Kato et al., 2008; Peisley 
and Hur, 2012). TLR22 preferentially recognizes long dsRNA (Matsuo et al., 2008).  The 
dsRNA-binding domain of PKR can bind to sequences 15-16bp in length, dsRNA lengths 
of >30bp are required to initiate dimerization, autophosphorylation, and activation of 
PKR (Heinicke et al., 2009). OAS requires a minimal length of 18-20bp dsRNA for 
activation, but higher enzymatic activity is seen with longer dsRNA (Peisley and Hur, 
2012).  TLR3 requires a minimal dsRNA length of 39-48bp for activation (Leonard et al., 
2008).  
   Secondly, longer dsRNA molecules support the binding of more PRRs along 
their length. For example, RIG-I multimerizes along a dsRNA molecule, the longer the 
dsRNA molecule the more RIG-I can bind, and more bound RIG-I means a stronger 
activation of downstream signaling pathways  (Binder et al., 2011). TLR3 affinity for 
dsRNA increases with dsRNA length, and longer dsRNA molecules support the assembly 
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of more TLR3 dimers along its length, triggering a stronger downstream signaling 
pathway (Leonard et al., 2008). 
 Finally, in addition to multimerization, a contributor to the length effects might 
be translocation of certain PRRs along the dsRNA molecule (Binder et al., 2011).  RIG-I 
was found to translocate along dsRNA without unwinding the molecule.  In the presence 
of 5`tripshophates, RIG-I uses ATP hydrolysis to translocate along one strand of dsRNA 
(Myong et al., 2009).  The duration of translocation increases with dsRNA length and is 
hypothesized to affect the strength of downstream signaling pathways (Myong et al., 
2009; Schmidt et al., 2011).  It is important to note that in the study done by Myong and 
colleagues long dsRNA molecules were only 50bp in length; more exploration into 
longer lengths of dsRNA would be beneficial (Myong et al., 2009).    
1.3.8 Sequence Dependence 
Attempts to elucidate dsRNA sequence motifs necessary for PRR binding have 
been largely unsuccessful.  Most PRRs appear to bind dsRNA based on its unique helical 
structure as opposed to its sequence (Peisley and Hur, 2012).  PKR binds without 
sequence specificity (Lemaire et al., 2008).  An exceptions is OAS, where there appears 
to be four critical base pairs in the minor groove of the dsRNA which may be necessary 
for binding (Kodym et al., 2009).  Additionally, RIG-I ligands generally have a uridine- 
or adenosine-rich ribonucleotide sequence (Saito and Gale, 2008).  RNA sequences with 
5`triphosphates are a powerful PAMP for RIG-I (Myong et al., 2009).  Despite what is 
known about dsRNA PRRs, the relationship between dsRNA-length and –sequence and 
immune response still remains largely unknown.   
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1.4 Type I Interferons 
IFNs are glycoproteins that are responsible for activating both the innate and 
adaptive immune responses against both viral and microbial infections (Dorner et al., 
1973, Fensterl and Sen, 2009). The two key antiviral type I IFNs in mammals are 
classified as either IFNα or β with 15 IFNα subtypes and a single IFNβ subtype (Hertzog 
and Williams, 2013). Rainbow trout have at least 5 type 1 IFNs classified as two groups. 
Group 1 consists of IFNs containing 2 cysteine residues and a single disulphide bond. To 
date, three rainbow trout interferon genes have been classified as group 1: IFN1, IFN2, 
and IFN5 (Chang et al., 2009).  Group 2 type 1 interferons are composed of IFNs 
containing 4 cysteine residues and two disulphide bonds. In rainbow trout, two group 2 
IFNs have been identified: IFN3 and IFN4 (Purcell et al., 2009; Chang et al., 2009).  
Viral dsRNA is a potent inducer of type I IFN, one dsRNA molecule being 
sufficient to induce IFN production (Marcus and Sekellick, 1977).  In mammals the 
dsRNA PRRs such as TLR3 and the RLRs activate transcription factors: IRF3/7 and NF-
kB that bind to the positive elements of the IFN promoter regions inducing transcription. 
IFNs likely follow the same protein synthesis pathway as other cytokines; proteins are 
synthesized in the rough endoplasmic reticulum via the secretory protein synthesis 
pathway, modified in the Golgi apparatus, and secreted by exocytosis (Stanley and Lacy, 
2010).    
IFNs inhibit viral replication and infection independent of viral species, by 
inducing an antiviral state in virus infected cells and neighbouring uninfected cells 
(Fensterl and Sen, 2009). Type 1 IFN receptors are cell surface receptors that are 
ubiquitously expressed (Fensterl and Sen, 2009).  Type 1 interferons signal through a 
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common heterodimeric receptor, IFNABR, which is comprised of subunits IFNAR1 and 
IFNAR2 (David et al., 2012; Goodbourn et al., 2000). IFNAR1 and IFNAR2 belong to 
class II helical cytokine receptor family (de Weerd et al., 2007).   
When IFN is bound to IFNABR the Janus tyrosine kinases JAK1 and TYK2 
phosphorylate transcription factors STAT1 and STAT2 (Fensterl and Sen, 2009).  The 
activated STATs form a heterodimer and recruit interferon-regulatory factor 9 (IRF9) to 
produce a STAT1-STAT2-IRF9 complex called ISGF-3 (Fensterl and Sen, 2009; David 
et al., 2012).  This complex translocates into the nucleus and activates interferon-
stimulated genes (ISGs) through binding to the interferon-sensitive response element 
(ISRE) within the promoter of the ISGs (Fensterl and Sen, 2009).  
I.5 Interferon-Stimulated Genes 
ISGs are a varied group of proteins that have many different actions within the 
cell but all work together to inhibit virus replication (Fensterl and Sen, 2009).  Many 
ISGs have been identified in teleost fish, including vig1-10 and Mx1-3 (O’Farrell et al., 
2002).  The Mx family has been identified in a wide range of species and consists of 
dynamin-related members of the large GTPase super-family (DeWitte-Orr et al., 2007).  
In rainbow trout, Mx1 and Mx3 are localized in the cytoplasm whereas Mx2 is localized 
in the nucleus (Leong et al., 1998).  In mammalian models Mx proteins have been shown 
to exhibit significant antiviral activity against many different viruses including vesicular 
stomatitis and the influenza virus (Leong et al., 1998; Pavlovic et al., 1990; Staeheli et 
al., 1986).  In mammals Mx proteins appear to block viral replication at an early stage. 
Human MxA protein has been shown to bind to the nucleocapsids of Thogoto virus 
blocking transport into the nucleus and preventing transcription of the viral genome 
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(Kochs and Haller, 1999).  Atlantic salmon Mx1 protein was found to inhibit the 
replication of a fish virus, infectious pancreatic necrosis virus and Japanese flounder Mx 
was able to inhibit fish rhabdoviruses (Larsen et al., 2004; Caipang et al., 2003). 
Virus-induced genes (vigs) are a group of proteins that are upregulated during 
virus infections. Rainbow trout vig1, a homologue to mammalian viperin or cig5, is 
proposed to be involved in the virus-induced synthesis of enzymatic cofactors in the nitric 
oxide pathway (Boudinot et al., 1999).  Vig2 has been characterized as an interferon-
responsive gene, its function is currently not known (Boudinot et al., 2001).  Vig3 is an 
ubiquitin-like protein that has high similarity to the mammalian ISG15 (Verrier et al., 
2011).  ISG15 has demonstrated antiviral activity against a variety of viruses and target 
proteins through an isgylation pathway (Verrier et al., 2011).  In Ebola virus infections 
ISG15 inhibits viral budding by preventing ubiquitination of a viral protein (Malakhova 
and Zhang, 2008).  Vig4 is homologous to the mammalian ISG56/ISG58 and encodes a 
teinoic acid- and interferon-inducible protein that contains tetratricopeptide repeats. The 
mammalian protein homologue (ISG56) has been shown to interfere with protein 
synthesis (Verrier et al., 2011; Robertsen 2008). 
1.6 Antiviral State 
The accumulation of ISGs within a cell results in the establishment of an antiviral 
state.  The antiviral state inhibits the replication of DNA and RNA viruses (Samuel, 
2001).  This has been observed in both in vitro and in vivo studies (Samuel, 2001).  Many 
virus infections that have been studied in cell culture systems are hindered at the primary 
step of the virus replication cycle, the synthesis of viral polypeptides (Samuel, 2001).  
Some viruses may be inhibited at different points in their multiplication cycles, for 
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example some myxoviruses and rhabdoviruses are inhibited before transcription (Samuel, 
2001).  
Previous studies have demonstrated the antiviral properties of poly I:C in fish and 
fish cell lines. Poly I:C transfected into a Chinook salmon embryo cell line resulted in an 
antiviral state against infectious pancreatic necrosis virus (Jensen et al., 2002).  4 species 
of whole salmon were injected with poly I:C and demonstrated antiviral responses when 
challenged with infectious hematopoietic necrosis virus or erythrocytic necrosis virus 
(Eaton, 1990).   
1.7 Fish Viruses 
1.7.1 Viral Hemorrhagic Septicemia Virus  
 VHSV infects a wide range of freshwater and saltwater species of fish.  It belongs 
to the Rhabdoviridae family of viruses, has an 11kb single-stranded negative-sense non-
segmented RNA genome, and is a lytic virus whose cytopathic effect (CPE) is cell death 
(Purcell et al., 2012).  The VHSV genome consists of 6 open reading frames encoding for 
6 proteins.  VHSV replicates in the endothelial cells of blood capillaries, leucocytes, 
haematopoietic tissues and nephron cells (Essbauer and Ahne, 2001).     
There are four distinct genotypes of VHSV (I-IV) and it infects over 70 teleost 
fish species from many diverse aquatic environments (Kim and Faisal, 2010).  Genotype 
IV encompasses isolates found in North America, Japan and Korea (Kim and Faisal, 
2010), while the VHSV subgroup IVb, which is used in the present study, is specific to 
the Great Lakes (Cornwell et al., 2011).  The Great Lakes subgroup IVb is particularly 
virulent and has a wide host range (Pierce and Stepien, 2012; Kim and Faisal, 2010).  
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VHSV was first identified in the North American Great Lakes in 2003 (Great Lakes 
Commission, 2011; Pierce and Stepien, 2012). There are no treatments or vaccines 
available for VHSV-IVb (Kipp et al., 2013) and to our knowledge nothing is known of 
the effects of VHSV-IVb produced dsRNA on the immune response.  VHSV is an 
important pathogen in Canadian waters and requires further study to understand how the 
virus interacts with the host immune system.  
1.7.2 Chum Salmon Reovirus  
Chum salmon reovirus (CSV) is a dsRNA virus that was isolated from adult chum 
salmon (Oncorhynchus keta) in a Japanese hatchery (Winton et al., 1981).  CSV is a non-
enveloped virus with an icosahedral double capsid and has a genome consisting of 11 
segments (Winton et al., 1987).  CSV infection results in cell fusion to create large 
multinucleated cells called syncytia (DeWitte-Orr and Bols, 2007).  This unique 
cytopathic effect (CPE) of the virus is easily observed under light microscopy.  CSV 
replicates in many cell lines from many different species of fish including rainbow trout 
and Chinook salmon (DeWitte-Orr and Bols, 2007).  
1.8 Rainbow trout  
 Rainbow trout (Oncorhynchus mykiss) is a fresh water teleost fish species often 
used in aquaculture.  Rainbow trout are readily infected by VHSV in aquaculture, in a 
laboratory setting, and in the wild, and in Europe rainbow trout are considered one of the 
most susceptible species found in European fisheries (Snow et al., 1999).  Rainbow trout 
are an important contributor to the economy through both aquaculture and sport fishing; 
rainbow trout are one of the top five sport fishes in North America (Fisheries and Oceans 
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Canada, 2010).  Rainbow trout farming occurs in almost every province in Canada and 
Ontario is the largest producer of trout (Fisheries and Oceans Canada, 2011).  Rainbow 
trout, whole animals and cell lines, are often used as a model for immunological studies 
and there is an existing knowledge base of rainbow trout type 1 IFN and ISGs (Zou et al., 
2007; Tafalla et al., 2008). 
1.9 Cell Lines 
Cell culture is frequently used in the study of virology (Leland and Ginocchio, 
2007).  Cell culture was utilized for the current study over whole animals for numerous 
reasons.  Using fish cell lines as opposed to intact fish limits the need for sacrificing 
animals.  Fish cell lines are easy to culture; they grow at room temperature and do not 
require some of the special maintenance required for mammalian cells (e.g. CO2 or 
special incubators) (Fryer and Lannan, 1994).  Using a cell line allows the researcher to 
focus on a single cell type.  Results are attained faster than with whole animals and the 
cost is lower (Bols et al., 2005).  Four fish cell lines were used in this study: three from 
rainbow trout and one from Chinook salmon.  RTG-2 was the main cell line used to 
characterize dsRNA responses, as its IFN and dsRNA-mediated immune response has 
been somewhat characterized; the remaining cell lines were utilized for specific reasons 
relating to an assay.  A brief background on these four cell lines is described below.             
1.9.1 RTG-2  
RTG-2 is a rainbow trout gonadal cell line derived from both male and female 
gonads (Wolf and Quimby, 1962).  RTG-2 is readily infected by VHSV and responds to 
extracellular poly I:C (DeWitte-Orr et al., 2007; Tafalla et al., 2008).  Previous studies 
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found unstimulated RTG-2 cells constitutively express low levels of IFN2 but no 
detectable amounts of IFN1; however, both IFN1 and IFN2 are strongly upregulated in 
response to poly I:C (Zou et al., 2007).  IFN3/4 is expressed in rainbow trout ovaries but 
has not been detected in RTG-2 (Zou et al., 2007).  The ISGs Mx1-3 and vig1 are 
upregulated in response to poly I:C and Chum salmon reovirus in this cell line (DeWitte-
Orr et al., 2007).       
1.9.2 RTG-P1  
RTG-P1 is RTG-2 stably transfected with a luciferase gene controlled by the Mx1 
promoter (Collet et al., 2004).  RTG-2 cells were transfected with a vector (pGL3-
prMx1-Basic-Neo) that contains an Mx1-promoter upstream of a firefly luciferase gene 
(Collet et al., 2004).  RTG-P1 has been shown to produce luciferase upon stimulation 
with poly I:C (Collet et al., 2004).   In this study, RTG-P1 was used as a part of a 
quantifiable reporter assay to measuring ISG-promoter activation in response to different 
dsRNA molecules.  
1.9.3 RTgutGC 
RTgutGC is an epithelial rainbow trout (Oncorhynchus mykiss) cell line 
developed from the intestine (Kawano et al., 2010).  Little is known with regards to the 
type 1 interferon response in RTgutGC cells; rainbow trout gut tissue expresses IFN2 
constitutively (Zou et al., 2007). RTgutGC was utilized in this study in the functional 
interferon assay because it was found to be a better IFN producer than RTG-2 in response 
to dsRNA.  
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1.9.4 CHSE-214 
CHSE-214 is an epithelial Chinook salmon (Oncorhynchus tshawytscha) embryo 
cell line (Lannan et al., 1984).  The cell line is effective for use in both detecting and 
propagating salmonid fish viruses (Lannan et al., 1984).  Chum salmon reovirus (CSV) 
infects and replicates within CHSE-214 cells (Winton et al., 1981; DeWitte-Orr et al., 
2007).  It appears that CHSE-214 lacks cell surface dsRNA receptors as it cannot respond 
to extracellular dsRNA (Jensen et al., 2002).  The cell line is able to respond to 
extracellular interferon (Nygaard et al., 2000). CHSE-214 was used in the functional 
interferon assay in this study, as it can respond to interferon but not the extracellular 
dsRNA (Jensen et al., 2002; Nygaard et al., 2000).  
1.10 Cell Viability Assay 
Carboxyfluorescein diacetate acetoxymethyl ester (CFDA-AM) is a cell viability 
indicator that has been used with fish cells (DeWitte-Orr et al., 2005; Schreer et al., 
2005).  It is a non-toxic dye that is retained within viable cells and cleaved by enzymatic 
esterases to a fluorescent product. Fluorescent CFDA is a measure of membrane integrity 
and can be measured using a multi-well plate reader (Schreer et al., 2005).  RTG-2 and 
CHSE-214 cell viability has previously been monitored using CFDA-AM (DeWitte-Orr 
et al., 2005).  In this study this cell viability assay was used to measure virus-induced cell 
death.    
The functional interferon assay and antiviral assay both measured the 
effectiveness of a stimulant, interferon or dsRNA, in establishing a protective antiviral 
state.  To measure the antiviral state cells were challenged with a virus and cell viability 
was measured to demonstrate any protection against the virus.  If the stimulant was able 
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to produce an antiviral state, fewer cells would be killed and cell viability would be 
higher in these groups.  Other methods of measuring viral infection or replication include 
using a green fluorescent protein virus vector, plaque assays, and quantitative PCR 
(Ferreira et al., 2013; Purcell et al., 2006).  CFDA-AM is ideal for this study as it is a 
quantitative assay without the subjectivity of counting plaques.  CFDA-AM effectively 
measures cell viability in any virus infected cell and does not have the viral specificity of 
a viral-reporter vector, such as GFP, or PCR, which was important to this study as two 
different viruses were used.       
1.11 Project Aims 
The goal of the present study was to better understand dsRNA induced innate 
immune responses in rainbow trout cell lines. There is a basic understanding as to how 
fish cells respond to poly IC; however, nothing is known of the effects of more relevant 
dsRNA molecules such as in vitro transcribed dsRNA, and the effects of length, whether 
with poly I:C or in vitro transcribed dsRNA, are is largely unexplored in fish cells as 
well.  The main hypothesis for the present project was that dsRNA, either synthetic or in 
vitro transcribed based on a viral genome, would induce a robust immune response within 
rainbow trout cells.  Specifically it was hypothesized that both dsRNA molecule would 
induce the production of type 1 IFN, ISGs, and an antiviral state in rainbow trout cells. 
Based on what was observed in mammals, it was hypothesized that the dsRNA would 
induce responses in a length-dependent manner with longer molecules inducing a greater 
magnitude of response compared to shorter molecules, and that sequence would have no 
effect on the immune response. Finally, it was hypothesized that  poly I:C would induce a 
stronger response than the in vitro transcribed molecules. To address these hypotheses 
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four main objectives were explored: 
1. To characterize the IFN response to dsRNA in rainbow trout cells using RT- PCR and 
a functional IFN assay 
2. To characterize the ISG response to dsRNA in rainbow trout cells using RT- PCR and 
a Mx1-reporter assay 
3. To characterize the dsRNA-induced antiviral state in rainbow trout cells using an 
antiviral assay 
4. To identify any potential length effects of dsRNA on the magnitude of the innate 
immune response using tools developed in objectives 1-3. 
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CHAPTER 2: MATERIALS AND METHODS 
2.1 Cell Lines 
Four cell lines were used in this study, Chinook salmon embryo (CHSE-214), 
rainbow trout gut (RTgutGC), rainbow trout gonad (RTG-2), and the transgenic RTG-2 
(RTG-P1). CHSE-214, RTgutGC and RTG-2 were obtained from N. Bols (University of 
Waterloo) and RTG-P1 was obtained from B. Collet (University of St. Andrews).  All 
cell lines were grown in 75cm2 plastic tissue culture flasks (BD Falcon, Bedford, MA, 
USA) at room temperature in Leibovitz’s L-15 media (HyClone, Logan, UT, USA) 
supplemented with 10%v/v fetal bovine serum (FBS) (Corning, Manassas, VA, USA) 
and 1%v/v penicillin/streptomycin (P/S) (10mg/mL streptomycin and 10000U/mL 
penicillin) (Fisher Scientific, Fair Lawn, NJ, USA).  RTG-P1 media was supplemented 
with an additional 100µg/mL of G418 neomycin (Sigma-Aldrich, St Louis, MO, USA).  
2.2 Virus Propagation  
Viral hemorrhagic septicemia virus (VHSV) was propagated on monolayers of 
Epithelioma papulosum cyprini (EPC), and chum salmon reovirus (CSV) was propagated 
on CHSE-214.  Virus containing media (5%v/v FBS (Corning)) was collected 4-7 days 
post-infection, filtered through a 0.45µm filter (Nalgene, Rochester NY, USA) and kept 
frozen at -20oC for short-term storage and -80oC for long-term storage.  
50% Tissue culture infective dose (TCID50)/mL values were estimated using the 
Reed and Muench calculator (Reed and Muench, 1988).  To estimate the TCID50/mL the 
cell line used to propagate the virus was seeded into 96-well plates (BD Falcon, Franklin 
Lakes, NJ, USA) at 3x104cells/well.  Serial dilutions of the virus were used to infect 6 
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wells each of the host cell line.  After a 7-day incubation wells were monitored for 
cytopathic effects and the Reed and Muench calculator was used (Appendix A1). 
2.3 dsRNA 
2.3.1 Poly I:C  
 Poly I:C  was stored in stock solutions of 10 mg/mL for regular (Sigma-Aldrich, 
St Louis, MO, USA) and low molecular weight (LMW) poly I:C (InvivoGen, San Diego, 
CA, USA) and 1mg/mL for high molecular weight (HMW) poly I:C (InvivoGen, San 
Diego, CA, USA) diluted in phosphate buffered saline (PBS) (HyClone, Logan, UT, 
USA) based on manufacturers suggestions.  Average length was estimated based on the 
smear produced by running 1µg of poly I:C on a 1% agarose (Fisher Scientific, Fair 
Lawn, NJ, USA) gel with 5µg of O’GeneRuler 1kb PLUS DNA Ladder (Fermentas, 
Carlsbad, CA, USA) The gel was stained with 0.5µg/mL ethidium bromide (Fisher 
Scientific, Fair Lawn, NJ, USA).  Poly I:C aliquots were stored at -20oC.     
2.3.2 In Vitro Transcribed dsRNA 
dsRNA was transcribed in vitro using the MegaScript RNAi kit (Ambion by Life 
Technologies, Carlsbad, CA, USA) following the manufacturers instructions summarized 
in Figure 2.1.  Fragments of the VHSV-IVb genome were amplified by RT-PCR using 
sequence specific primers linked 5` to a T7 RNA polymerase promoter (3`-
TAATACGACTCACTATAGGG-5`) (Figure 2.2, Table 2.1).  T7 RNA polymerase 
synthesized complimentary RNA strands from the template that were annealed to form 
dsRNA.  The fragments created were 200bp (v200) and 1264bp (v1200) in length and 
based off a randomly chosen section of the VHSV genome (Figure 2.2).  
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Figure 2.1 In vitro transcription of dsRNA. 
Using an RNAi Megascript kit (Ambion) dsRNA can be synthesized from template 
DNA.  This process makes use of T7 RNA polymerase that is capable of synthesizing 
RNA from DNA.  In order for T7 polymerase to recognize the DNA template, T7 
promoter sequences must be added to the target sequence, on both the sense and antisense 
strand.  This is done using gene specific primers (forward and reverse) with the T7 
promoter sequence attached to the 5` end.  After T7 transcription the product is a mix of 
nucleic acids, a DNase and RNase treatment exploits the differential degradation of 
ssRNA and DNA to end up with a pure dsRNA product.     
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Figure 2.2 VHSV genome and dsRNA fragments.  
A simplified schematic of the VHSV genome showing two random fragments chosen for 
amplification for dsRNA synthesis.  The v200 is 200bp in length and the v1200 is 1264bp 
length. Adapted from Ammayappan, A., Vakharia, V.N. (2009).  
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2.3.3 Native dsRNA 
RTgill-W1 cells were infected with VHSV-IVb (3.16 x 103 TCID50/mL).  After a 
4-day incubation total RNA was extracted.   Native dsRNA was isolated using a lithium 
chloride (LiCl) (Sigma-Aldrich, St Louis, MO, USA) precipitation method and gel 
extraction method.  In both cases total RNA was extracted using TRIzol (Life 
Technologies, Carlsbad, CA, USA) following manufacturers instructions.  The LiCl 
extraction has been previously described (Diaz-Ruiz and Kaper, 1978).  4M LiCl was 
added to total RNA to a final concentration of 2M.  The solution was incubated at -20oC 
for 30 min and centrifuged at 17000xg for 30min at 4oC.  8M LiCl was added to the 
supernatant to a final concentration of 4M.  The solution was incubated at -20oC for 30 
min and centrifuged at 17000xg for 30min at 4oC.  The resultant pellet was air-dried, 
suspended in DNA quality H2O, and quantified using a NanoDrop lite Spectrophotometer 
at 260nM (Thermo Scientific, Waltham MA, USA).   
For the gel extraction method 10-40µL of total RNA was run on a 1%w/v agarose 
(Fisher Scientific) gel and stained with 0.5µg/mL ethidium bromide (Fisher Scientific).  
The dsRNA band was excised and extracted using the Qiagen gel extraction kit (Qiagen, 
Hilden, Germany).  The dsRNA was quantified using a NanoDrop lite Spectrophotometer 
at 260nM (Thermo Scientific). 
2.3.4 Acridine Orange Staining   
 A novel method was developed based on Pichlmair and colleagues 2009.  Total 
RNA and dsRNA extractions were run on a 1%w/v agarose (Fisher Scientific) gel.  The 
resulting gel was stained with 30µg/mL acridine orange in MilliQ water (Farrel, 2005) 
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(Sigma-Aldrich, St Louis, MO, USA) in H2O for 10min.  The gel was run under hot 
running tap water for 20min to facilitate destaining (Farrel, 2005), then under cool 
running tap water for 5min to counteract the slight softening from the hot water.  The gel 
was placed in room temperature H2O overnight.  The gel was visualized using a 
VersaDoc Imager (Bio-Rad, Hercules, CA, USA) set to 2 channels, 695BP Blue LED and 
530BP Blue LED.   
2.4 RT-PCR 
2.4.1 dsRNA Stimulation  
RTG-2 cells were split 1:2 into 75cm2 flasks (BD Falcon) or seeded at 5x105 
cells/well into 6-well plates (BD Falcon, Franklin Lakes, NJ, USA) and allowed to attach 
overnight.  Cells were treated with growth media (10% FBS (Corning)) containing 
50µg/mL regular poly I:C (Sigma-Aldrich), 1.5nM HMW poly I:C (InvivoGen), 1.5nM 
LMW poly I:C (InvivoGen), 1.5nM v200 or 1.5nM v1200 in vitro transcribed dsRNA, or 
untreated control media.  After 24h total RNA was extracted.   
 2.4.2 RNA Extraction 
Total RNA was extracted using TRIzol (Life Technologies) according to the  
manufacturers instructions. TRIzol (Life Technologies) reagent was added to attached 
cells and the growing surface was scraped to facilitate cellular material collection.  The 
TRIzol/cell mixture was collected and mixed with chloroform (Sigma-Aldrich, St Louis, 
MO, USA).  Centrifugation at 16100xg for 15min at 4oC resulted in phase separation. 
RNA phase was collected and combined with 100% isopropanol (VWR, West Chester 
PA, USA).  Centrifugation at 16100xg for 10min at 4oC was used to precipitate and pellet 
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RNA. RNA was washed using 80% ethanol (Sigma-Aldrich, St Louis, MO, USA) and 
centrifuged at 16100xg for 5min at 4oC.  RNA pellet was dried briefly to remove residual 
ethanol and resuspended in DNA quality water (Fisher Scientific).  RNA was quantified 
using a NanoDrop Lite Spectrophotometer (Thermo Scientific) and stored at  -80oC until 
use.  
2.4.3 cDNA Synthesis 
cDNA was synthesized using GoScript reverse transcriptase (Promega, Madison, 
WI, USA).  Briefly, 2µg of RNA were incubated with 0.5µg oligo-(dT)23 primer (Sigma-
Aldrich, St Louis, MO, USA) for rainbow trout genes or random hexamer (Sigma-
Aldrich, Canada) for viral gene fragments at 70oC for 5min and immediately placed on 
ice for 5min.  A reaction mix containing 1x GoScript Reaction Buffer (Promega, 
Madison, WI, USA), 1.5mM MgCl2 (Promega, Madison, WI, USA), 0.5mM each 
deoxynucleotide triphosphate (dNTP) (Sigma-Aldrich, St Louis, MO, USA), and 160U 
GoScript reverse transcriptase (Promega, Madison, WI, USA) was added to the RNA and 
oligo-(dT) (Sigma-Aldrich) mix.  The reaction was incubated at 25oC for 5min, 42oC for 
1h, and held at 4oC.  Half the resulting cDNA was diluted 1:3 in DNA quality water 
(Fisher Scientific, Fair Lawn, NJ, USA) and stored at 4oC for short-term storage or -20oC 
for long-term storage.              
2.4.4 PCR Reactions 
PCR reactions were carried out using GoTaq Flexi DNA Polymerase (Promega, 
Madison, WI, USA).  All PCR reactions contained: 2µl of cDNA, 1x Green GOTaq Flexi 
Buffer (Promega, Madison, WI, USA), 0.2mM each dNTP (Sigma-Aldrich, St Louis, 
MO, USA), 1.25U GoTaq Flexi DNA Polymerase (Promega, Madison, WI, USA), 
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1.5mM MgCl2 (Promega, Madison, WI, USA), 0.5µM forward primer (Sigma-Aldrich, St 
Louis, MO, USA), 0.5µM reverse primer (Sigma-Aldrich, St Louis, MO, USA) and up to 
25µL nuclease-free water (Fisher Scientific).  The primer sequence, cDNA dilution, and 
annealing temperature for each gene-specific primer set can be found in Table 2.1.  The 
PCR reactions were conducted in a T100 Thermal Cycler (Bio-Rad, Hercules CA, USA) 
at the following cycle conditions: 95oC for 2min, 27 cycles of: 95oC for 45s, specific 
annealing temperature for 45s, 72oC for 45s followed by 72oC for 10min and held at 4oC.  
For the amplification of viral fragments for dsRNA synthesis elongation time was 1min 
30s and cycle number was 34.  β-Actin was included as a positive control.  5-10µl of 
product was run on a 1%w/v agarose (Fisher Scientific) gel and stained with 0.5µg/mL 
ethidium bromide (Sigma-Aldrich) for visualization with a VersaDoc Imager (Bio-Rad) 
set to UV transillumination.  Data shown are representative of three independent 
experiments. 
2.5 Functional Interferon Assay 
A novel functional interferon assay was developed.  RTgutGC was seeded at 
7x105cells/well into 6-well plates (BD Falcon); cells were allowed to attach overnight.  
Media was removed from wells and cells were treated with one of: 3nM v1200, 3nM 
v200, 3nM LMW poly I:C (InvivoGen), 3nM HMW poly I:C (InvivoGen) or control 
media (10%v/v FBS (Corning)) and incubated for 24h.  CHSE-214 was seeded at 3x104 
cells/well in 96-well plates (BD Falcon) and allowed to attach overnight.  Conditioned 
media from RTgutGC cells was collected and centrifuged at 10xg for 5min to remove 
debris.  CHSE-214 cells were treated with RTgutGC-conditioned, media for 24h.  Cells 
were rinsed with PBS (HyClone) and infected with CSV (TCID50/mL 1.21x105) in 
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1%v/v FBS (Corning) containing media.  After a 5-day incubation at 17oC cell viability 
was measured using CFDA-AM (Invitrogen, Carlsbad, CA, USA) (Figure 2.3).  Data 
from five independent experiments were statistically analyzed using a one-way ANOVA 
and Tukey post-hoc test performed using Kaleidagraph software. 
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 Figure 2.3 Functional interferon assay.   
Rainbow trout cells were stimulated for 24h with dsRNA, to allow for IFN to accumulate 
in the media.  The conditioned media was then collected and used to treat  CHSE-214 
cells for 24h.   During this time any present interferon would be stimulating an antiviral 
state within the CHSE-214 cells.  Afterwards the CHSE-214 cells were infected with 
chum salmon reovirus (CSV). 5 days post-infection cell viability was measured using 
CFDA-AM. If functional interferon was present in the media, treated cells would have a 
protective, antiviral state and more cells would survive the virus infection.  Assay was 
completed in a 96-well plate; a 12-well plate was shown for simplicity.    
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Table 2.1 RT-PCR primers.   
Primer sequences, including product size, annealing temperature (TA), and reference for 
primers or accession number. *indicates undiluted cDNA was used, all other products were 
amplified from cDNA diluted 1:3.  
Gene or 
fragment 
Primer Sequence 5`-3` 
Product 
size 
(bp) 
TA 
(oC) 
Reference or 
Accession Number 
β-actin 
F-ATCGTGGGGCGCCCCAGGCACC 
R-CCTCCTTAATGTCACGCACGATTTC 
514 53 DeWitte-Orr et al., 2007 
Mx1 
F-ATGCCACCCTACAGGAGATGATATGA 
R-AAAAAGGATAACAAAGGACT 
452 54.4 DeWitte-Orr et al., 2007 
Mx2 
F-TTGGTAGACAAAGGCACAGAGGA    
R-AAGTTCTTTCCAGAGCGATCCA 
500 65 DeWitte-Orr et al., 2007 
Mx3 
F-ATGCCACCCTACAGGAGATGATT   
R-CCACAGTGTACATTTAGTTG 
380 53 DeWitte-Orr et al., 2007 
Vig1* 
F-CAGTTCAGTGGCTTTGACGA 
R-ACAAACTCCTCAAGGTATGG 
232 65 DeWitte-Orr et al., 2007 
Vig2 
F-GCATTGGTACACGCGTAG 
R-TTGAGGAGAATTAGCTACACA 
279 55 Boudinot et al., 2001 
Vig3 
F-TGCTTGCCCTCGTGAATCAG 
R-CATCAGTCTCAGCGATGATTCAAA 
225 55 O’Farrell et al., 2002 
Vig4 
F-CATTCCTTTGCCTAGGGCATCT 
R-TGTCTCCTGATGTGCCTCAC 
613 55 O’Farrell et al., 2002 
rtIFN1* 
F-AATTCCTGTGTATCACCTGCCA  
R-GATGATCAGTACATCTGTGCTG 
182 57 Tafalla et al., 2008 
rtIFN2* 
F-TGGATCCAACACCACTTCGG 
R-GCTCAGTACATCTGTCCCACA 
467 58 AJ580911  
rtIFN3/4 
F- TGGTTGAGCATTTGCCTGAC 
R- TCAGAGTAACCGAGCCTCCA  
400 55 AJ829673.1 
v200* 
F - TTCAGATGAGGGGAGCCACA 
R - TCGCATGATCTGGCCATCAA 
200 62 GQ385941 
v1200* 
F - ACGGACAAGCGAAGGACTAC 
R - TCGCATGATCTGGCCATCAA 
1200 52  GQ385941 
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2.6 Mx1-Promoter Reporter Assay 
The Mx1-promoter reporter assay was performed as shown in Figure 2.4.  The 
novel assay was modified from Collet and colleagues (2004).  RTG-P1 cells were seeded 
at a density of 5x105 cells/well in a 6-well plate (BD Falcon).  Cells were allowed to 
attach overnight.  Media was removed from all wells, cells were treated with media 
containing 1.5nM of either regular poly I:C (Sigma-Aldrich), HMW poly I:C 
(InvivoGen), LMW poly I:C (InvivoGen),  v1200,  or v200 in vitro transcribed molecules 
or untreated control media.  After 24h cells were removed from the growing surface with 
trypLE (Life Technologies, Grand Island, NY) and collected through centrifugation at 
1400xg for 5min.  The cell pellet was re-suspended in 100µl of Steady-Glo luciferase 
substrate (Promega, Madison, WI, USA) and incubated for 40min in the dark. 90µl of the 
substrate/cell mixture was plated into a 96-well plate (BD Falcon) and luminescence was 
measured in relative luminescent units (RLUs) using a Synergy HT plate reader (BioTek, 
Winooski, VT, USA).  Data from three independent experiments were statistically 
analyzed using a one-way ANOVA and Tukey post-hoc test performed using 
Kaleidagraph software.  
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Figure 2.4 Mx1-promoter reporter assay protocol.  
 RTG-P1 cells were plated in 6-well plates and allowed to attach overnight.  Treatment 
wells were treated with dsRNA for 24h.  After 24h cells were removed from wells, a 
Steady-Glo luciferase substrate was added, incubated, transferred to a new microphage 
and luminescence was measured. Wells with more Mx1-promoter activation expressed 
more luciferase and therefore more luminescence.   
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2.7 Antiviral Assay 
A novel antiviral assay was developed to measure the establishment of the 
antiviral state (Figure 2.5).  RTG-2 cells were seeded at 3x104 cells/well in 96-well plates 
(BD Falcon).  Cells were allowed to attach overnight. Media was removed from wells 
and replaced with media containing 3nM of either  v1200,  v200,  LMW poly I:C 
(InvivoGen), or  HMW poly I:C (InvivoGen) or control media (all with 10%v/v FBS 
(Corning)).  This concentration of dsRNA was determined to be optimal based on an 
antiviral assay concentration gradient using 1.5nM to 30nM poly I:C (Appendix A2).  
After 6h or 24h the media was removed and the cells were rinsed with PBS (HyClone).  
Cells were infected with VHSV (3.16x105 TCID50/mL) in 1%v/v FBS (Corning) media.  
After a 7-day incubation at 17oC cell viability was measured using CFDA-AM 
(Invitrogen).  Data from three independent experiments were statistically analyzed using 
a one-way ANOVA and Tukey post-hoc test performed using Kaleidagraph software.  
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Figure 2.5 Antiviral assay protocol.  
RTG-2 cells were treated with dsRNA or growth media alone for 24h to allow dsRNA to 
mount an antiviral state. Afterwards cells were challenged with VHSV.   7-days post 
infection a CFDA-AM cell viability assay was used to measure dsRNA-induced cell 
protection.  A 96-well was use for the assay; a 12-well plate is shown for simplicity.     
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2.8 Cell Viability Assay 
After incubation with the virus, the media was removed and the cells were rinsed 
with PBS (HyClone).  A solution containing 4µM CFDA-AM (Invitrogen) was added to 
wells.  The plate was incubated in the dark for 1h.  Fluorescence was measured in a 
Synergy HT plate reader (BioTek) at Ex 485nM Em 530nM. Data from three independent 
experiments were statistically analyzed using a one-way ANOVA and Tukey post-hoc 
test performed using Kaleidagraph software.  
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CHAPTER 3: RESULTS 
3.1 Synthetic dsRNA characterization 
To confirm dsRNA lengths, 1µg of each type of poly I:C was run on an agarose 
gel and stained with ethidium bromide (Figure 3.1).  All poly I:C produced a smear of 
mixed length nucleic acids.  LMW poly I:C was estimated to have an average length of 
300bp, HMW poly I:C to have an average length of 3000bp, and regular poly I:C to have 
an average length of 500bp.   
In vitro transcribed dsRNA was synthesized using a DNA template amplified 
from the VHSV genome.  Resulting dsRNA fragments were 200bp and 1264bp long and 
called v200 and v1200 respectively.  The dsRNA products were confirmed as single 
bands of the appropriate length by agarose gel electrophoresis (Figure 3.2).   
3.2 Native dsRNA isolation characterization 
Total RNA collected from uninfected and VHSV infected RTgill-W1 cells were 
run on a 1%w/v agarose gel and visualized using an acridine orange stain and VersaDoc 
Imager (BioRad). The infected cells showed a robust high molecular weight green 
dsRNA band that was not present in uninfected control cells (Figure 3.3).  The dsRNA 
band was larger than the 20kb band found in the DNA ladder.  Both uninfected and 
infected cells produced 2 red ssRNA bands, likely 28S and 18S rRNA.    
Two methods were used to isolate the dsRNA from the total RNA samples.  
Firstly, the dsRNA was isolated using a gel extraction method and run on a gel to check 
integrity and purity (Figure 3.4).  The dsRNA band appears of similar size to the original 
dsRNA band and to be free of ssRNA contamination.   The final concentration of the 
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dsRNA extracted from four infected 75cm2 flasks of cells was 14.5ng/µL in 50µL.  The 
second method used to isolate native dsRNA used a lithium chloride based extraction.  
The dsRNA product from this method was visualized on an acridine orange stained 
agarose cell (Figure 3.4). The resulting dsRNA product appeared to have some 
contaminating ssRNA present.  In addition the dsRNA did not run on an agarose gel in a 
manner that was consistent with the pre-extracted sample.  As sufficient amounts of 
native dsRNA to dose cells with were unable to be achieved with the methods described, 
the induced IFN, ISG and antiviral states of fish cells were evaluated using poly I:C and 
in vitro transcribed dsRNA. Native dsRNA-induced cell responses will be measured in 
future studies once better methods of extraction are developed. 
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Figure 3.1 Characterizing length of different types of poly I:C.   
1µg of low- (LMW), 1µg of high- (HMW) molecular weight poly I:C and 1µg  or 10µg  
of regular poly I:C were run on a 1%w/v agarose gel, stained with ethidium bromide and 
visualized by UV transillumination.   The average length was estimated to be 300bp for 
LMW, 3000bp for HMW, and 500bp for regular poly I:C.  
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Figure 3.2 In vitro dsRNA synthesis products.  
Two fragments, 1200bp and 200bp, of the VHSV genome were amplified using RT-PCR 
to create a DNA template.  The DNA template was used in a T7 RNA polymerase 
reaction to create complementary strands of ssRNA.  The ssRNA strands annealed to 
create dsRNA of known length and sequence.  Different amounts of DNA templates were 
run on a gel for quantification.  The purified, synthesized dsRNA was also run on a gel to 
confirm size and quantity (E1 and E2 represent two separate elutions of the final dsRNA 
product from the same column).  1/400th of the final product was run on a gel.  The “pre-
cleanup” lane shows the dsRNA prior to digestion with nucleases and column cleanup, it 
was shown for v1200 as a representation of the effectiveness of the cleanup.  
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Figure 3.3 Native dsRNA produced by VHSV.   
RTgill-W1 cells were infected with VHSV for 4 days.  Total 
RNA was extracted and run on a 1%w/v agarose gel then 
stained with acridine orange.  Acridine orange stains single-
stranded nucleotides red and double-stranded nucleotides 
green.   The two ssRNA bands present in both uninfected and 
infected samples are likely 28S and 18S RNA.  
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Figure 3.4 Native dsRNA isolation products.   
 
RTgill-W1 cells were infected with VHSV for 4 days.  Total RNA was extracted and 
dsRNA was isolated using a gel extraction method, or a lithium chloride based extraction 
method.  The total RNA and extracted dsRNA, ~1µg of each, were run on an agarose gel 
then stained with acridine orange and visualized by UV transillumination.  Acridine 
orange stains single-stranded nucleotides red and double-stranded nucleotides green.     
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3.3 RT-PCR analysis of IFN and ISG production in response to extracellular dsRNA  
The expression profile of type 1 IFN and ISG transcripts was determined in 
dsRNA-stimulated and unstimulated RTG-2 cells.  In response to 50µg/mL (~151.5nM) 
poly I:C for 24h, IFN1 and IFN2 and all ISGs (Mx1-3 and vig1-4) were upregulated 
(Figure 3.5).  In response to 1.5nM HMW poly I:C, v200, or v1200 for 24h, IFN1 and 
IFN2 were upregulated compared to controls however less upregulation was seen 
compared to the higher concentration of poly I:C.  The greatest upregulation for IFN1 and 
IFN2 appeared to be in response to HMW poly I:C.  There was little to no detectable 
IFN1 or IFN2 transcript production seen after treatment with LMW poly I:C. All ISGs 
were clearly upregulated with low levels of constitutive expression, with the exception of 
vig1, which was not detected in response to 1.5nM treatments and vig2 which was 
strongly upregulated by 50µg/mL poly I:C but very little by 1.5nM v200, v1200 and 
HMW treatments.  LMW poly I:C did not result in detectable amounts of vig2 transcripts. 
β-actin was included as a positive control, constitutive expression was detected across all 
groups.  
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Figure 3.5 IFN and ISG transcript expression following dsRNA treatment as 
measured by RT-PCR.   
RTG-2 cells were stimulated with (A) 50µg/mL poly I:C or (B) 1.5nM high- (HMW) or 
low- (LMW) molecular weight poly I:C or (C) 1.5nM in vitro transcribed dsRNA 200bp 
(v200) or 1200bp (v1200) for 24h.  After the incubation period RNA was extracted, 
cDNA was synthesized and RT-PCR was performed using gene specific primers. Most 
IFNs and ISGs were upregulated in response to extracellular dsRNA.  β-Actin was 
included as a housekeeping gene control. Results are representative of three independent 
trials.        
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3.4 Functional interferon production in response to extracellular dsRNA  
Functional interferon activity was measured using an assay developed in lab.  
IFN-containing media was collected from RTgutGC cells stimulated with extracellular 
3nM dsRNA and used to treat CHSE cells.  An uninfected control given fresh media and 
an infected control treated with conditioned media from unstimulated RTgutGC cells 
were also included.  The cells were challenged with CSV for 5-days and CFDA-AM was 
used to determine cell viability.  The average relative fluorescent units (RFUs) obtained 
were as follows: uninfected control 1103.26 +/- 24.15 RFUs, infected control 973.86 +/- 
20.97 RFUs, LMW poly I:C 1015.62 +/- 21.57, HMW poly I:C 1024.26 +/- 27.54 RFUs. 
This increase in cell viability indicates decreased viral effectiveness and thus protective 
IFN activity (Figure 3.6).  This demonstrates a protective effect provided by the 
functional interferon produced by stimulated RTgutGC but no apparent length effects 
  
 
 
49 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6 HMW and LMW poly I:C induced interferon results in a protective state.   
Interferon-conditioned media from RTgutGC cells stimulated with 3nM LMW or HMW 
poly I:C for 24h was used to treat CHSE-214 cells.  Cells were challenged with chum 
salmon reovirus (TCID50/mL 1.21x105). 5 days post-infection cell viability was 
measured using a fluorescent cell viability indicator, CFDA-AM. An uninfected control 
with fresh media and an infected control with conditioned media from unstimulated 
RTgutGC cells were included. Statistical analysis was performed by a one-way ANOVA 
with Tukey post-hoc test (*p<0.05, ** p<0.001, ***p<0.0001), n=5.    
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3.5 Mx1-promoter activation in response to extracellular dsRNA 
ISG promoter activity was evaluated using an Mx1-promoter reporter assay. After 
RTG-P1 cells were stimulated with 1.5nM of dsRNA luciferase expression was 
quantified. With either poly I:C or in vitro transcribed dsRNA there was a significantly 
greater amounts of luminescence seen in the dsRNA treated groups compared to the 
untreated control. In the HMW/LMW poly I:C experiment the relative luminescence 
units (RLUs) measured were as follows: control 5884.12 +/-1972.63 RLUs, LMW poly 
I:C 35812.67 +/-5198.50 RLUs, HMW poly I:C 51964.33 +/-3916.58 RLUs.  In the 
v200/v1200 experiment the RLUs measured were: control 1212.21 +/-213.23 RFUs, 
v200 14988.83 +/-2246.13, v1200 23068.42 +/-3059.18 RLUs, poly I:C 19268.54 +/-
3752.494 RLUs.  The longer dsRNA molecules, HMW poly I:C and v1200, were able to 
induce a significantly greater magnitude of response compared to the shorter molecules, 
LMW poly I:C and v200 respectively (Figure 3.7, Figure 3.8). Regular poly I:C was used 
in the same experiments as the v200 and v1200, the poly I:C produced a greater response 
than the v200 and a slightly (not significantly) lower response compared to the v1200.  
There was variability between the two experiments, however there was consistency 
within an experiment.  This is seen quite clearly between the controls (5884.12 RLUs and 
1212.21 RLUs) and one possible explanation is the luminescent substrate reagent losing 
efficacy over time.     
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Figure 3.7 Mx-promoter activity in response to high molecular weight (HMW) or 
low molecular weight (LMW) poly I:C.   
RTG-P1 cells were treated with 1.5nM of either HMW or LMW poly I:C for 24h. After 
24h a luciferase substrate was added to cells and luminescence was measured using a 
plate reader. These data are an average of three independent experiments. Statistical 
analysis was performed by a one-way ANOVA with Tukey post-hoc test (*p<0.01, 
**p<0.0001), n=3.   
  
0 
10000 
20000 
30000 
40000 
50000 
60000 
Control LMW HMW  
R
el
at
iv
e 
Lu
m
in
es
ce
nt
 U
ni
ts
 
(R
LU
s)
 
** 
* 
** 
 
 
52 
 
0	  5000	  
10000	  15000	  
20000	  25000	  
30000	  
Control	   v200	   v1200	   Poly	  I:C	  Rela
tive	  Lu
minesc
ent	  Un
its	  
(RLUs)
	  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8 Mx1-promoter activity in response to two lengths of in vitro transcribed 
dsRNA or poly I:C.   
RTG-P1 cells were treated with 1.5nM in vitro transcribed dsRNA of 200bp (v200),  
1200bp (v1200) lengths or poly I:C for 24h. After 24h a luciferase substrate was added to 
cells and luminescence was measured using a plate reader.  These data are an average of 
three independent experiments. Statistical analysis was performed by a one-way ANOVA 
with Tukey post-hoc test (*p<0.01, **p<0.001, ***p<0.0001), n=3.  
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3.6 Antiviral activity in cells stimulated with extracellular dsRNA 
To look at the antiviral effects of dsRNA RTG-2 cells were stimulated with 3nM 
dsRNA for 24h or 6h and then challenged with VHSV.  To asses potency of dsRNA a 
range of molar concentrations of poly I:C were used in a preliminary study (Appendix 
A2). Cells treated with dsRNA demonstrated higher levels of cell viability after the 7-day 
infection as measured using CFDA-AM.  Treatments with either poly I:C or in vitro 
transcribed dsRNA  significantly protected cells against the VHSV infection compared 
with untreated controls (Figure 3.9, Figure 3.10). Near complete protection was observed 
following 6h and 24h dsRNA treatments, and no length effects were observed.  The 24h 
treatment experiment cell viability results were as follows: uninfected control 1211.97 +/-
23.37RFUs, infected control 692.17 +/-122.76 RFUs, v200 1237.28 +/- 221.63 RFUs, 
v1200 1244.55 +/-160.55 RFUs.  The 6h treatment experiment cell viability results were 
as follows:  uninfected control 1082.7 +/-131.70 RFUs, infected control 734.67 +/-129.40 
RFUs, v200 1091.28 +/-71.12 RFUs, v1200 1073.00 +/-100.54 RFUs, LMW poly I:C 
1049.64 +/-75.76 RFUs, HMW poly I:C 1060.33 +/-134.96 RFUs.   
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Figure 3.9 In vitro transcribed dsRNA-induced antiviral state following 24h 
treatment  
RTG-2 cells were treated with 3nM in vitro transcribed dsRNA of 200bp (v200) or 
1200bp (v1200) lengths for 24h. Cells were challenged with VHSV (3.16 x 105 
TCID50/mL). 7-days pi cell viability was measured using the fluorescent indicator dye, 
CFDA-AM. An uninfected control was included as was an infected control that was not 
pretreated with dsRNA.   These data are an average of three independent experiments. 
Statistical analysis was performed by a one-way ANOVA with Tukey post-hoc test * = 
significant difference from infected control (*p<0.01), n=3.  No significant difference 
was found between dsRNA treatment groups. 
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Figure 3.10 Poly I:C or in vitro transcribed dsRNA-induced antiviral state following 
6h treatment.   
RTG-2 cells were treated with 3nM in vitro transcribed dsRNA of 200bp (v200) or 
1200bp (v1200) lengths or HMW or LMW poly I:C for 24h. Cells were challenged with 
VHSV (3.16 x 105 TCID50/mL). 7-days post infection cell viability was measured using a 
fluorescent indicator dye, CFDA-AM. An uninfected control was included as was an 
infected control that was not pretreated with dsRNA.  These data are an average of three 
independent experiments.  Statistical analysis was performed by a one-way ANOVA with 
Tukey post-hoc test * = significant difference from infected control (*p<0.05, **p<0.01), 
n=3.   No significant difference was found between dsRNA treatment groups. 
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CHAPTER 4: DISCUSSION 
 
The main hypothesis of this project was that dsRNA, both synthetic and in vitro 
transcribed dsRNA based on a viral genome, would induce a robust immune response 
within rainbow trout cells.  A secondary hypothesis was that rainbow trout cells would 
respond to dsRNA in a length dependent manner; longer molecules will produce a greater 
magnitude of response.  A third hypothesis was that poly I:C would produce a stronger 
response than the in vitro transcribed dsRNA.  To test these hypotheses three aspects of 
the immune response were measured in response to dsRNA, the IFN response, ISG 
response, and the antiviral state. The DeWitte-Orr lab has previously shown that fish 
viruses produce dsRNA in fish cells, validating the use of fish cells and viruses for this 
study (unpublished data).  The majority of the work done on fish cells using dsRNA has 
relied on the synthetic form of dsRNA, poly I:C.  This is the first time low- and high- 
molecular weight poly I:C have been used in fish cells to explore innate immunity and 
length effects.  To increase biological relevancy dsRNA molecules were synthesized in 
vitro with a more natural sequence and defined length and sequence.  dsRNA was 
successfully generated in the lab from a template derived from the VHSV genome.  This 
is the first time a VHSV based dsRNA molecule has been synthesized and used to treat 
fish cells.  
Many of the protocols used in this study were novel and designed as part of the 
study.  The functional interferon assay was the first of its kind utilizing established 
rainbow trout cell lines as the interferon producer, CHSE-214 as the responding cell, and 
cell viability measured using CFDA-AM as an end point.  The antiviral assay is similar to 
previous antiviral assays (DeWitte-Orr et al., 2005), the protocol required optimization 
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for a VHSV infection within RTG-2 pretreated with molar concentrations of extracellular 
dsRNA and using the CFDA-AM cell viability dye as an endpoint measurement.  RT-
PCR has previously been used to identify ISG transcripts in rainbow trout cells, however 
the gene-specific primer set for IFN2 and the v200 and v1200 VHSV dsRNA templates 
were novel and optimized accordingly.  The primers for mx1-3 and vig1 had previously 
been used with RTG-2 cells; the primers for vig2-4 came from previously completed 
studies, however, had not been optimized for use in RTG-2 (Table 2.1).  None of the 
primers had been used in the DeWitte-Orr lab and required optimization.  The mx1-
promoter reporter assay required adjustment for nanomolar concentrations of dsRNA and 
it required a novel protocol to be developed to accurately measure luciferase expression 
using a Steady-Glo reagent (Promega).  
4.1 dsRNA characterization  
As mentioned above, this is the first time dsRNA has been made using a fish virus 
genome template.  Two different lengths of dsRNA were produced, 1264bp (v1200) and 
200bp (v200).  The lengths were chosen as representative short and long dsRNA 
molecules.  While the v200 was considered the ‘short’ molecule in this study compared to 
the v1200, when compared to endogenous dsRNA (<30bp) v200 is still a long dsRNA 
molecule that is capable of being sensed by host cell PRRs.  To avoid number of 
molecules acting as a confounding variable, cells were treated in nanomolar 
concentrations as opposed to weight concentrations.  This ensured an equal number of 
molecules/cell for each dsRNA length; thus differences in responses can be attributed to 
length as opposed to differences in number of molecules/cell. Previous studies used molar 
concentrations of in vitro transcribed dsRNA molecules when exploring length effects 
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(DeWitte-Orr et al., 2010; Binder, 2011).  For poly I:C, which is of mixed length, the 
approximate average length was used for molarity calculations.  This is one way in vitro 
molecules are more relevant for studying length effects compared to poly I:C, as the 
length of the molecules is homogenous and not mixed, this allows for accurate molar 
dosing.  A concentration gradient was used to determine the optimal dsRNA molarity for 
the antiviral assay, 3nM was chosen as a molarity sufficient to induce a strong response 
and low enough to conserve dsRNA.  The same molarity was used for the functional 
interferon assay. 1.5nM was found to be sufficient for the RT-PCR panel and the Mx1-
promoter assays; as these assays required greater volumes of dsRNA the reduced 
concentration was preferable. 
To isolate and characterize dsRNA an acridine orange staining protocol was 
optimized from Pichlmair colleagues 2009.  Acridine orange is a useful tool as it stains 
double stranded nucleic acids green and single stranded nucleic acids red.  Acridine 
orange is an incredibly robust stain and destaining was difficult.  If there are suboptimal 
staining conditions single stranded nucleic acids stain green instead of red, making them 
indistinguishable.  Once optimized acridine orange was used to detect dsRNA production 
in virus infected rainbow trout cells (Figure 3.3). The dsRNA molecules produced by 
VHSV were large, which is consistent with the genome size of VHSV (11.2kb). The 
dsRNA on the gel appears to be approximately 20kb in length; however, the size could be 
more accurately determined using a DNA ladder with larger bands and running the 
samples on a lower percent agarose gel. Regardless, the isolated dsRNA band was large, 
likely larger than the virus genome. The reason for this is yet unknown and is currently 
being investigated   One possible explanation is that the genome is self-annealing to 
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create the long fragments.  Similar results were found in one study that demonstrated 
encephalomyocarditis virus, a positive sense ssRNA virus with a genome size of 
approximately 7.7kp, produced dsRNA molecules larger than 12kb, longer than the 
genome size (Pichlmair et al., 2009; Shi et al., 2010).  Positive sense ssRNA viruses have 
been shown to produce long dsRNA fragments, >3000bp and ~8000bp  (Kato et al., 
2008; DeWitte-Orr et al., 2009).  Interestingly, it has been suggested that negative sense 
ssRNA viruses, one of which is VHSV, do not produce dsRNA (Weber et al., 2006), 
however studies have found VHSV and vesicular stomatitis virus (VSV), both negative 
sense ssRNA viruses, produce dsRNA (unpublished data; Kato et al., 2008).  This is the 
first time that fish virus native dsRNA has been observed using an acridine orange 
staining method.   
Two different techniques were used to isolate the native dsRNA and the 
extraction was checked for effectiveness using the acridine orange stain.  A lithium 
chloride extraction method and an agarose gel extraction method were attempted (Figure 
3.4).  After the LiCl extraction the dsRNA sample contained a small amount of ssRNA 
contamination. Also, the dsRNA no longer ran the same way on a gel as before it was 
extracted, possibly because of residual salts.  Attempts to elucidate the effects of native 
dsRNA would be hindered if the dsRNA molecules were modified during the extraction 
process.  The gel extraction was successful in isolating dsRNA with no visible ssRNA 
contamination and the dsRNA appeared similar to the pre-extraction dsRNA molecule; 
however, the resulting dsRNA concentrations were too low to be practical for dosing 
cells, even when the protocol was scaled up to use more starting material.  Unfortunately 
most protocols for isolating dsRNA have been developed for extracting plant pathogen 
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genomic dsRNA, which would be more abundant in the infected cells as compared to 
what is expected with replicative by-product viral dsRNA (Morris and Dodds, 1979; Li et 
al., 2007).  The LiCl based extraction completed in this study was developed for use with 
plant viruses (Diaz-Ruiz and Kaper, 1979).  While a promising beginning it is evident 
more work is needed to fully optimize the protocols and isolate workable concentrations 
of viral dsRNA.   
 
4.2 dsRNA induced antiviral responses 
The central hypothesis of this study was that dsRNA molecules would induce 
innate immune responses, more specifically the production of IFN, ISGs, and an antiviral 
state. A variety of assays were utilized to test this hypothesis, the results of which are 
discussed below.  
4.2.1 IFN response 
The present study provided several different lines of evidence supporting the 
hypothesis that dsRNA induces an immune response in rainbow trout cells.  The first step 
in the dsRNA-mediated pathway is the production of type 1 interferon.  While RT-PCR is 
an important assay to measure transcript presence within a cell, it cannot be assumed that 
transcript production means functional protein is being produced.  There are post-
transcriptional modifications that could influence whether or not the transcript becomes a 
functional protein.  For example many interferons undergo post-translational 
modifications, such as glycosylation (Fensterl and Sen, 2009). The functional interferon 
assay was developed in the current study and differed from previous assays similar in 
nature.  Previous studies have used interferon-conditioned media from rainbow trout cells 
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to treat other rainbow trout cells (DeWitte-Orr et al., 2007; Saint-Jean and Perez-Prieto, 
2006).  In these studies the conditioned media from dsRNA treated cells is transferred to 
new cells to measure IFN activity. Even though the dsRNA treated cells are washed prior 
to IFN accumulation in the media, dsRNA is still likely to be present and would induce 
IFN in the recipient cells, masking the effects of the IFN as rainbow trout cells can 
respond to both IFN and extracellular dsRNA.  The assay developed for this study is 
similar to that developed by Congleton and Sun (1996) in that it utilizes CHSE-214 cells 
that cannot respond to extracellular dsRNA. Congleton and Sun transferred conditioned 
media from rainbow trout anterior kidney cells stimulated with poly I:C or the fish virus 
infectious hemapoetic necrosis virus onto CHSE-214.  After allowing time for the IFN to 
induce a response, the cells were infected with the virus, incubated to allow for virus 
replication, and then fixed and stained with crystal violet. The optical density was 
measured to quantify virus-induced cytolysis (Congleton and Sun, 1996).  The assay 
developed for the current study was novel in its use of RTgutGC cells as the producer of 
interferon conditioned media, and the use of a fluorescent indicator dye, CFDA-AM, as 
the end point cell viability measure.   
There was a protective state in CHSE-214 cells treated with IFN-conditioned 
media from dsRNA-stimulated RTgutGC (Figure 3.6). This suggests that functional 
interferon is being produced and is able to initiate immune pathways resulting in a 
protective state within the cell.  This is the first study to demonstrate the ability of 
RTgutGC to produce functional interferon in response to any type of dsRNA.  The ability 
for in vitro transcribed dsRNA to stimulate the production of functional IFN has not yet 
been tested but will be in future experiments.   
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RTgutGC was used for this assay as opposed to RTG-2 because it appears that 
CHSE-214 mounts a stronger antiviral state in response to the IFN produced by 
RTgutGC cells (unpublished data).  The mechanism behind this is currently unknown, 
however it is possible that RTgutGC either produces a type one IFN that RTG-2 does not, 
or produces the same IFNs but in greater amounts.  Another hypothesis is that RTgutGC 
interferon may peak closer to 24h (the time at which media was collected) than the RTG-
2 cells, producing more accumulated IFN in the media.  Preliminary results using RT-
PCR suggest at 24h RTgutGC cells stimulated with poly I:C express IFN1 and IFN2 
robustly, and that unstimulated cells express IFN2 constitutively (Appendix A3).    It is 
also notable that the cell death observed in the functional interferon assay virus control 
was not as advanced as might be expected after a 5-day infection.  Previous experiments 
in the lab have shown that when CHSE-214 cells are untreated and infected with CSV for 
5-days there is between 50-40% cell death compared to the uninfected control.  The 
experiments performed in the present study yielded approximately 15% cell death 5-days 
post infection.  The hypothesized explanation is the conditioned media from unstimulated 
RTgutGC contains constitutively expressed IFN.  Thus cells treated with unstimulated 
RTgutGC conditioned media are still being exposed to accumulated IFN within the media 
that appears to have a protective state, however media from dsRNA-stimulated cells 
appear to produce more IFN and more than one type.          
Interestingly, the expression profile of IFNs in CHSE-214 has been preliminarily 
investigated using rainbow trout IFN primers (Appendix A4). It appears as though 
CHSE-214 itself produces three type 1 IFN-like transcripts that align similarly to the 
rainbow trout IFNs IFN1, IFN2, and IFN3/4, and the IFN expression in CHSE-214 
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appears to be constitutive as all IFNs were seen in unstimulated cells. The identity of 
each band was confirmed by sequencing.  The CHSE sequence obtained using rainbow 
trout IFN1 primers had a 90% similarity to rainbow trout IFN1 (121/134 identities), 
rainbow trout primers for IFN2 resulted in a sequence with 87% similarity to rainbow 
trout IFN2 (263/303 identities), and IFN3/4 primers resulted in an 85% similarity to 
rainbow trout IFN3 (542/636 identities).  This would suggest CSV must have 
mechanisms of overcoming IFNs produced by CHSE-214, a fascinating area for future 
research.   
The functional interferon assay suggested that interferons were being produced in 
rainbow trout cells in response to dsRNA stimulation, however the assay does not 
provide any information as to what type 1 IFN subtype are being produced.  To verify the 
functional interferon results and delineate which type 1 IFN subtypes are produced RT-
PCR was used.  Three type 1 IFNs (IFN1, IFN2, IFN3/4) were surveyed, although only 
IFN1 and IFN2 were identified in RTG-2 cells, IFN3/4 has been shown to not be 
expressed in RTG-2 (Zou et al., 2007).  Both IFN1 and IFN2 were upregulated in RTG-2 
in response to poly I:C (Figure 3.5), which was expected based on previous studies where 
IFN1 expression was upregulated in RTG-2 cells stimulated with poly I:C, less robustly 
than IFN2 but not at concentrations lower than 1µg/mL poly I:C (Zou et al., 2007). 
Though not quantitative, our study also shows IFN1 being induced at lower levels 
compared with IFN2 in response to poly I:C. To our knowledge no one has investigated 
the effects of LMW or HMW poly I:C and in vitro transcribed dsRNA in IFN expression.   
The in vitro transcribed dsRNA and LMW poly I:C did not seem to be as effective at 
inducing IFNs as the HMW poly I:C, inducing trace amounts compared with untreated 
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controls.  This could be because the HMW poly I:C has an average length more than 
double the length of the v1200 and ten times greater than LMW poly I:C.  These results 
need to be pursued using quantitative RT-PCR methods to confirm differences in levels 
of IFNs. Also, different time points should be considered as IFN transcript production 
can be cyclical, and by 24h the peak of IFN production for the in vitro transcribed 
molecules may be missed.  
The present study investigated the expression of IFN1, 2 and 3/4 at the transcript 
level; however, rainbow trout also express IFN5.  IFN5 transcript has been previously 
found in poly I:C stimulated RTS-11 and RTG-2 cells (Chang et al., 2009).  This has yet 
to be repeated and attempts to repeat the study as part of the current study and identify 
IFN5 transcripts in RTG-2 after poly I:C stimulation were unsuccessful.  IFN3/4 was not 
detected, which corresponds with previous studies that were unable to detect IFN3/4 in 
RTG-2 cells (Zou et al., 2007).  The results seen in this study suggest that fish respond to 
in vitro transcribed dsRNA somewhat differently compared to mammalian models.  In 
mice cells in vitro transcribed dsRNA was able to robustly induce type 1 interferon, the 
response appeared much stronger compared to the results seen in fish (DeWitte-Orr et al., 
2009).  This may be due to the different species or different cell types, the mammalian 
work was done in embryonic fibroblasts and this study utilized gonadal fibroblasts.  
4.2.2 ISG response 
The next stage in the innate immune pathway occurs when functional IFN leaves 
the cell and acts through its cognate receptor to induce the expression of a series of genes, 
ISGs (Robertsen, 2006).  Western blot analysis would be ideal for measuring ISG 
expression; however, few antibodies exist against fish ISGs. Thus RT-PCR was 
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performed, which has the benefit of making it possible to assay multiple ISGs quickly. 
The panel consisted of vig1-4 and Mx1-3 and was optimized using 50µg/mL of poly I:C, 
which is a concentration commonly used in the literature; however it is a high dose for 
this study where 50µg/mL of regular poly I:C with an average length of 500bp is 
approximately 150nM.  Vig1 and mx1-3 were chosen as they have previously been 
shown to be upregulated in RTG-2 cells in response to poly I:C (DeWitte-Orr et al., 
2007; Tafalla et al., 2007).  The ISGs vig2, vig3, and vig4 were chosen because they have 
been identified in rainbow trout cells and Vig3 and vig4 have important human 
homologues. Vig2, vig3, and vig4 have been identified in virus-infected rainbow trout 
leukocytes from head-kidney (O’Farrell et al., 2002; Boudinot et al., 2001) but this is the 
first time they have been measured in a dsRNA stimulated cell line. Thus the induction of 
vig2, vig3, and vig4 in RTG-2 cells following poly I:C treatment is a novel finding.  This 
is also the first time in vitro transcribed dsRNA has been shown to induce any ISGs in 
rainbow trout cells.  
Both poly I:C and in vitro transcribed dsRNA molecules were able to induce a 
variety of ISGs in RTG-2 cells (Figure 3.5).  Vig3, vig4, and Mx1-3 were robustly 
upregulated in all treatment groups. Vig1 was only induced at higher concentrations of 
poly I:C, higher concentrations of HMW, LMW poly I:C or in vitro dsRNA were not 
tested.  This is not inconsistent with previous experiments involving vig1 and RTG-2, 
where it was shown that vig1 expression was upregulated after 24h in RTG-2 cells treated 
with 50µg/mL poly I:C (DeWitte-Orr et al., 2007).   It is notable that ISG expression 
between treatments looks to be of similar strength despite the IFN transcripts appearing 
substantially less upregulated in RTG-2 treated with in vitro transcribed treatment groups 
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or LMW poly I:C.  One possible explanation is that IFN transcripts peak earlier than 24h. 
To test this hypothesis a time course could be performed to measure IFN transcript over 
time.  Another hypothesis is that there are other IFNs being produced that have not yet 
been measured in the current study, such as IFN5, a novel type 1 interferon subtype, or an 
interferon of a different type such as type III interferon.  It also is possible that the ISGs 
are being induced by an IFN-independent mechanism, as has been seen with mammalian 
ISG56 and ISG15 (Chew et al., 2009).  VHSV has been shown to induce vig1 in an 
interferon-independent fashion (Boundinot et al., 1999).  
Although not quantitative, the RT-PCR panel suggests that there are potential 
length effects seen in transcript production, as longer molecules produced more ISG 
transcripts, particularly between LMW and HMW poly I:C.  The difference between 
HMW and LMW looks to be larger than the v200 and v1200, the HMW (~3000bp) and 
LMW (~300bp) molecules are further apart in length compared to v200 and v1200 that 
could explain this trend.  The RT-PCR is valuable for insights into what ISGs are being 
produced in response to dsRNA; however, quantitative assays are needed to demonstrate 
significant length effects on the production of ISGs.    
 One such quantitative assay is the Mx1-promoter reporter assay.  RTG-P1 has 
previously been used to demonstrate the ability of poly I:C to activate the Mx1-promoter 
(Collet et al., 2004).  The present study used the RTG-P1 in a similar manner, treating the 
cells with poly I:C but also with in vitro transcribed dsRNA.  All extracellular dsRNA 
was able to significantly activate the Mx1-promoter (Figure 3.7; Figure 3.8). Longer 
dsRNA molecules stimulated the promoter more strongly compared with shorter lengths.  
These data will be discussed further in section 4.3.1.       
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4.2.3 Antiviral response 
The RT-PCR and Mx1-promoter reporter assay demonstrated the production of 
ISG transcripts and promoter activation, however it was unclear whether this was leading 
to a protective antiviral state.  An antiviral assay was developed to see if dsRNA was able 
to protect the rainbow trout cells from viral infection. Since the accumulation of ISGs 
results in an antiviral state, the antiviral state assay is in effect a functional ISG assay.  
The results demonstrate a protective state was induced following poly I:C or in vitro 
transcribed dsRNA treatment (Figure 3.9; Figure 3.10), as treated cells were viable 
following VHSV infection while those without dsRNA treatment died.  Poly I:C has been 
used in other studies to stimulate an antiviral state within fish cells (Jensen et al., 2002; 
Jensen and Robertsen, 2002; DeWitte-Orr et al., 2005).  A main difference between 
previous assays and the assay used in the present study was the concentration of poly I:C.  
Previous studies have used poly I:C concentrations such as 10µg/mL and 50µg/mL, 
whereas this assay was adjusted for low nanomolar concentrations of dsRNA, between 
0.396µg/mL – 5.94µg/mL (Jensen and Robertsen, 2002; DeWitte-Orr et al., 2005). In 
vitro transcribed molecules have not previously been shown to induce an antiviral state in 
fish cells.      
dsRNA was applied to cells in low amounts and there was still a robust antiviral 
state established; this reinforces how potent dsRNA is as an immunomodulating molecule 
(Marcus and Sekellick, 1977). With 24h of dsRNA treatment there was complete 
protection, no cell death was detected.  These high levels of cell viability could have been 
hiding potential dsRNA length effects. It was hypothesized that 24h was too long an 
incubation to elucidate length effects and 6h was tested.  At 6h there were no differences 
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seen between the v1200 and v200 in vitro transcribed molecules and the LMW and 
HMW poly I:C, as once again dsRNA induced complete protection of the monolayer. 
Shorter treatment times are currently being tested to attempt to explore length effects.  
This protocol may not be optimal for measuring length effects as there is a 7-day 
infection with VHSV, over the course of the 7-days the effects of different dsRNA 
treatments may equalize.  A shorter assay such as the Mx1-promoter assay that only 
involves a single 24h incubation, was better at capturing length effects.  
4.3 dsRNA features influencing immune responses  
 In addition to exploring the rainbow trout immune response to dsRNA, the 
characteristics of dsRNA that might influence the magnitude of the immune response 
were also examined.  Length and sequence are two features of dsRNA that were 
examined.  In addition the differences between commercially available poly I:C and in 
vitro transcribed dsRNA based on a fish viral genome sequence were also explored.  The 
findings are discussed in the following sections.   
4.3.1 Length effects 
It was hypothesized that longer dsRNA molecules would induce a greater 
magnitude of immune response compared to shorter molecules.  The Mx1-promoter assay 
demonstrates that fish cells have a more robust immune response to longer dsRNA 
molecules.  This is the first study to suggest the dsRNA-mediated innate immune 
response in fish is length dependent.  The Mx1-promoter assay showed statistically more 
activation in response to long dsRNA molecules compared to their shorter counterparts.  
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The RT-PCR indicated a similar trend for HMW and LMW poly I:C. These length effects 
were also suggested in the RT-PCR assay with both IFNs and ISGs. 
 The reason for length effects could be the PRR expression.  Many PRRs have 
been shown in mammalian models to show increased activation in response to longer 
lengths of dsRNA (Binder et al., 2011; Lemaire et al., 2008; Peisley and Hur, 2012).  
RIG-I is known to preferentially bind shorter dsRNA (< 1000 bp) however it has not yet 
been cloned in rainbow trout.  If RIG-I is not expressed then another receptor is binding 
the short dsRNA molecules such as v200, LMW poly I:C and regular poly I:C.  A human 
cell line transfected with Fugu TLR3 was treated with different lengths of in vitro 
transcribed dsRNA and 200bp created the most robust response (Matsuo et al., 2008).  
TLR3 could be compensating for the potential lack of RIG-I and be binding the v200.  In 
the same study human cells transfected with Fugu TLR22 responded to poly I:C and 
shorter lengths of poly I:C moderately, however the 1000bp in vitro transcribed dsRNA 
generated the most IFN-β activity (Matsuo et al., 2008).  If the these PRRs act in rainbow 
trout as they do in fugu, the in vitro transcribed dsRNA lengths used in the present study 
would target TLR22 (v1200) and TLR3 (v200) respectively. Both receptors are 
hypothesized to trigger the same downstream pathways via the adaptor molecule 
TICAM-1 (Kasamatsu, 2013). MDA5 is also present in rainbow trout and is able to bind 
poly I:C and mediate up-regulation of Mx1 (Chang et al., 2011). It is unclear at this time 
which PRRs are involved in the IFN, ISG and antiviral states monitored in the present 
assay. What is clear; however, is that longer dsRNA molecules are able to induce Mx1-
promoter activity significantly more than shorter dsRNA molecules.  This is similar to 
what has been previously seen in mammalian studies where longer dsRNA molecules 
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induced a greater magnitude of antiviral, ISG, and interferon response (DeWitte-Orr et 
al., 2009).   
4.3.2 Sequence effects 
It was hypothesized that sequence would not have an effect on the magnitude of 
the innate immune response.  The main emphasis of the current study was investigating 
the effects of in vitro transcribed dsRNA in rainbow trout cells with a comparison of two 
lengths, sequence was not fully investigated but some conclusions can be drawn for the 
role of sequence in the dsRNA mediated immune pathway.  In vitro transcribed dsRNA 
which had a more natural sequence and poly I:C which is not naturally produced by 
viruses both seemed to have similar effects on the rainbow trout cells, with length being 
the possible dictator of response intensity, not sequence. Poly I:C (~500bp) induced Mx1 
promoter activity somewhere between v200 and v1200, suggesting effect of length 
irrespective of sequence.  To fully elucidate the role of sequence more in vitro molecules 
would need to be produced with different sequences but the same length. Aside from the 
minor sequence requirements, such as the 4 critical base pairs for OAS or uridine- or 
adenosine-rich ribonucleotide sequences for RIG-I, there has been little evidence to 
suggest dsRNA sequence influences receptor binding (Kodym et al., 2009; Saito and 
Gale, 2008).  PKR and TLR3 bind without sequence specificity (Lemaire et al., 2008; Liu 
et al., 2008). However the effect of dsRNA sequence on innate immune responses has not 
been explored as well as dsRNA length in any animal model.    
4.3.3 Poly I:C vs. in vitro transcribed dsRNA 
Previous studies in mammals have suggested that poly I:C and in vitro transcribed 
dsRNA produce similar but not identical innate immune responses (DeWitte-Orr et al., 
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2009; Jiang et al., 2011).  Studies in mammals have shown differences between poly I:C 
and in vitro transcribed dsRNA molecules of similar length.  A study in murine cells 
examined the expression of a panel of ISGs in response to poly I:C and similar length in 
vitro molecules (DeWitte-Orr et al., 2009).  It was found that poly I:C induced some of 
the ISGs within the panel more strongly than in vitro molecules, however some ISGs 
were induced more greatly in response to in vitro transcribed molecules (DeWitte-Orr et 
al., 2009).  A different study in murine cells looked specifically at IFN-β production 
found greater production in response to in vitro molecules of similar length to poly I:C 
(Kato et al., 2006).   It is difficult to compare the poly I:C and in vitro transcribed data in 
many studies as the length of the poly I:C is often not reported.   
At the receptor level a notable difference has been identified between fish and 
humans.  When human TLR3 and a fish (Fugu) TLR3 were treated with poly I:C and in 
vitro transcribed dsRNA, the human TLR3 responded most strongly to the poly I:C 
whereas the fish TLR3 responded most strongly to in vitro transcribed dsRNA (Matsuo et 
al., 2008).  The hypothesis for the current study was that fish cells would show a greater 
immune response to poly I:C compared to in vitro molecules.  The data from the 
quantitative Mx1-promoter assay showed the poly I:C response was not significantly 
different from either in vitro transcribed treatment (Figure 3.8).  The poly I:C treatment 
fell between the v200 and v1200 in vitro transcribed dsRNA response.  The regular poly 
I:C stimulated slightly less promoter activity compared to the v1200 group and more than 
v200. While the average length is 500bp for the poly I:C, longer molecules are present 
within the group, possibly contributing to the higher expression which was closer to the 
v1200.  
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4.4 Conclusions  
This study investigated the effects of extracellular dsRNA on the innate immune 
system in rainbow trout cells.  Two types of dsRNA, poly I:C and in vitro transcribed 
dsRNA, were used to treat rainbow trout cells and the response was measured at each 
major step in the innate antiviral pathway. The novel findings from this study are 
twofold; firstly this was the first study to measure the effects of in vitro transcribed 
dsRNA on fish cells. It was determined that rainbow trout cells are able to respond to 
extracellular in vitro transcribed dsRNA through the induction of type 1 interferons, 
interferon-stimulated genes, and an antiviral state.  This response did not vary 
dramatically from the poly I:C induced response. Secondly, this was also the first study to 
investigate the effects of dsRNA length on the antiviral response in fish cells. Different 
lengths of dsRNA were used to show that rainbow trout cells show similar length effects 
to those seen in mammalian models, in which longer dsRNA molecules produce a greater 
magnitude of immune response.  In vitro transcribed dsRNA molecules are potent 
inducers of innate immune responses. 
The results from this study contribute to a better understanding of the host 
response to viral infection.  As dsRNA has the potential to be an antiviral therapy or 
vaccine adjuvant (DeWitte-Orr and Mossman, 2010), this data produces a knowledge 
base for possible future therapeutic agents.  Also, the innate immune system is well 
conserved between species and therefore understanding the fish innate immune pathway 
will provide insight into other species.   
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4.5 Future directions 
The next step to explore length effects is to expand the variety of lengths of in 
vitro dsRNA molecules.  Two different lengths of in vitro transcribed dsRNA were used 
in this study, expanding the number of lengths to include both longer and shorter 
molecules would further elucidate length effects.  In addition to length, sequence effects 
could be explored using the methods in this study.  One way to investigate sequence 
effects would be to create in vitro molecules of the same length and different sequences.  
It is unknown whether fish species other than rainbow trout respond to dsRNA in a 
length-dependent manner.  Other cell lines from rainbow trout and other species will be 
stimulated with dsRNA to see if there are differences in the dsRNA-mediated immune 
responses between fish species.   
Another future direction for this project is to extract native dsRNA molecules 
produced from a viral infection and stimulate cells with these naturally occurring 
molecules.  Some possible methods of extracting native dsRNA include using cellulose, 
lithium chloride or ammonium acetate extractions, immune-precipitation, or differential 
digestion (Attoui et al., 2000; Okuda and Hanada, 2001; Kaneko et al., 2011).  Many 
protocols for extracting dsRNA are designed for extracting dsRNA genome viruses from 
plants.  These protocols provide a good starting point for extracting viral dsRNA however 
they likely will require optimization.  After extraction, dsRNA molecules could be 
characterized for length, sequence, and abundance.  In addition, proteins associated with 
native dsRNA could be identified.  The dsRNA molecules could be used to stimulate 
cells so the natural immune response can be characterized.     
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Once native molecules are extracted and characterized it would provide the 
information for how to best mimic virally produced dsRNA.  It is hypothesized that the 
dsRNA produced by viruses will differ depending on the genome of the virus.  It is 
possible that a mix of in vitro transcribed molecules will be able to closely mimic the 
natural viral molecules and be able to be used in place of native molecules, which may be 
necessary if extracting native dsRNA proves to be difficult, costly, or results in very low 
yields of dsRNA or if researchers are looking to alter an aspect of the native dsRNA-
induced response.    
4.6 An integrative approach 
A more integrative biological understanding of a pathway can be obtained by 
looking at multiple levels of a pathway.  This study integrates the cellular and molecular 
mechanisms of the innate immune response with the whole cell response.  By studying 
different levels of response, a broader understanding of the cellular reaction is gained.  
This study was a cross-disciplinary and trans-disciplinary research project.   Techniques 
used were from numerous fields of biology, including cellular biology, molecular 
biology, virology, and immunology.  Aspects of the project that transcended biology 
included many of the methods that had chemistry components.  
The DeWitte-Orr lab is an integrative environment; many different projects come 
together for a common goal.  Other students in the lab are studying the extracellular 
dsRNA receptors, properties of cell lines, and other fish viruses; all of these projects 
relate back to the present project and results from this project impact other studies in the 
lab as well.  In addition the DeWitte-Orr lab collaborates with many different labs around 
Canada and the world.  It is very valuable to the lab to be able to work with other groups 
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of scientists.  Being able to integrate ideas and techniques from different areas 
strengthens our research and provides new directions for related studies. 
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Appendix A. Supplementary Figures 
A1 TCID50/mL Calculation Protocol.    
 
 
 
 
 
 
 
 
 
 
 
 
Appendix A1 Protocol for calculation of TCID50/mL for viral titres.    
The cell line used to propagate the virus was plated into a 96-well plate and allowed to 
attach overnight.  The virus stock was serially diluted 10-1- 10-6 dilutions.  100µL of 
virus was used to infect each well.  After a 7-day incubation cells are observed and the 
wells with cytopathic effects are counted, in this figure cytopathic effect is denoted with a 
red X.  The resulting numbers are used in the calculation of the TCID50 value (Reed and 
Muench, 1988). 
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A2 Determining the optimal dsRNA concentration to induce an antiviral state in 
RTG-2      
 
 
Appendix A2 Antiviral state established in RTG-2 in response to a range of poly I:C 
concentrations.   
RTG-2 cells were stimulated with a range of concentrations of poly I:C for 24h (1.5-30 
nM).  And then challenged with VHSV for 7-days.  Cell viability was measured using the 
fluorescent indicator dye CFDA-AM.  Ctrl NV = uninfected control; Ctrl V = infected 
control not pretreated with dsRNA. 
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A3 Interferon expression in a rainbow trout gut cell line (RTgutGC). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix A3 Interferon expression in a rainbow trout gut cell line (RTgutGC) as 
determined by RT-PCR. 
RTgutGC cells were left untreated or stimulated with 3nM HMW poly I:C for 24h.  RT-
PCR was used to examine expression of IFN1 and IFN2.  B-Actin (not shown) was also 
measured and found to be equally expressed between treated and control cells.  As a 
comparison the RT-PCR for RTG-2 stimulated with 1.5nM HMW poly I:C for 24h was 
included.   
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A4 Interferon expression in a Chinook salmon embryo cell line (CHSE-214) 
 
Appendix A4 Interferon expression in Chinook salmon 
embryo cell line (CHSE-214) as determined by RT-PCR.  
Rainbow trout primers for IFN1, IFN2, and IFN3/4 were used 
for RT-PCR with CHSE-214 cDNA.  PCR products were 
purified using a PCR clean-up kit and sent for sequencing.  
The top alignment completed with NCBI’s nucleotide BLAST 
was reported.  RT = rainbow trout CS = Chinook salmon.  
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Description Accession Query cover Identity 
Oncorhynchus mykiss type 1 interferon 
(IFN1), mRNA NM_001124531.1 99% 90% 
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Description Accession Query cover Identity 
Oncorhynchus mykiss type 1 interferon 2 
(IFN2 mRNA, complete cds FJ184359.1 72% 87% 
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CHSE - IFN3/4 
Alignment results: 
Description Accession Query cover Identity 
Oncorhynchus mykiss IFN3 gene for type 
1 interferon 3, exons 1-5 AM489417.1 63% 85% 
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Appendix B. Standard Operating Procedures 
B1 RT-PCR – RNA extraction and cDNA synthesis  
RNA Extraction 
1. Aspirate media from flask using Pasteur pipette.  For wells remove media by 
inverting the plate.     
2. Add 400µL (for a 75cm2 flask) of TRIzol reagent.  200µL for a 25cm2 flask.  
100µL for a well in a 6-well plate.  All subsequent reagent values are for 400µL 
TRIzol, adjust volumes as necessary if starting with less TRIzol.       
3. Spread TRIzol around flask until entire growing surface is coated.  Reagent will 
turn a milky-pink color. 
4. Use cell scraper to scrape down sides of the flask, scrape in the same direction. 
5. Transfer solution to 1.5mL Eppendorf tube. 
This stage can be stored at -80oC if necessary. 
6.  Add 80µl chloroform to tube and shake vigorously for 15s. Add chloroform in 
the fume hood. 
7. Incubate at room temperature for 3min. 
8. Centrifuge at max speed for 15min at 4oC.     
9. At this stage there should be a clear phase (RNA), white layer (DNA) and pink 
phase (protein and cell debris).  Remove clear top layer, transfer to new 
Eppendorf tube.  White and pink layer need to be disposed of in a appropriate 
waste container.     
10. To precipitate RNA add 200µl 100% isopropanol, shake for 15s.   
11. Incubate at room temperature for 10 min. 
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12. Centrifuge at max speed for 10 min at 4oC.  A very small white pellet will form.   
13. Carefully remove supernatant and discard. 
14. To wash the pellet add 400µl 80% ethanol.  Do not re-suspend pellet.  
15. Centrifuge at max speed for 5min at 4oC.   
16. Remove supernatant and discard. 
17. Invert tube and allow pellet to air dry over for approximately 10min. 
18. Add 10µl DNA quality H2O, re-suspend pellet. 
19. Incubate at 55oC for 10min. 
20. Store at -80oC.   
cDNA Synthesis 
1. Combine 2µg RNA (quantified using Nanodrop spectrophotometer) with 1µL 
primer (Oligo-dT23 or random hexamer).  Add DNA quality H2O to a final 
volume of 5µL. 
2. Using thermocycler, heat at 70oC for 5min, place in ice for at least 5min. 
3. Centrifuge briefly to prevent loss of solution.   
4. To the RNA and primer mixture add a reaction mixture containing: 
4µL GoScript 5x Buffer 
1.2µL MgCl2 
1µL GoScript Reverse Transcriptase 
1µL 10mM each dNTP mixture 
7.8µL DNA quality H2O  
5. Mix thoroughly.  Heat at 25oC for 5min, followed by 42oC for 1h. 
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6. Dilute cDNA as desired and store cDNA at 4oC for short term or -20oC for longer 
periods.    
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B2 Functional interferon assay 
Used to identify functional interferon present in media of stimulated cells.  RTgutGC was 
used as source of interferon however other cell lines could be used.  Cell density may 
need to be optimized for different cell lines.     
 
1. Plate RTgutGC cells at a density of 7x105 cells/well in a 6-well plate.  One well 
for each treatment and one for a control. 
2. Allow to attach overnight. 
3. Aspirate media.  Treat cells with 3nM of treatment, or fresh media for control. 
4. Incubate at room temperature for 24h. 
5. On same day as step 3 plate 3x104 CHSE-214 cells/well into 96-well plate.  6-
wells/treatment, 6-wells for control, and 6-wells for a non-infected control.  
6. Collect media from RTgutGC in microcentrifuge tubes.  Centrifuge at 10xg for 
5min. 
7. Remove media from 96-well plate, treat appropriate wells with 50µl of 
conditioned or control media. 
8. Incubate at room temperature for 24h. 
9. Remove media from 96-well plate, rinse cells with 100µL PBS. 
10. To all wells but no-virus control add 70µl 10-1 dilution of CSV made in 1%FBS 
media.  Add 1% FBS media to the control wells. 
11. Incubate at 17oC for 5 days. 
12. Measure cell viability using CFDA-AM.    
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B3 RTG-P1 luciferase reporter assay 
An assay for Mx1-promoter activity within RTG-P1 cells.  Steady-Glo reagent creates 
bubbles readily, take care when pipetting the reagent.    
 
1. Plate 5x105 RTG-P1 cells into wells of 6-well plate, 3 wells for control and 3 
wells/treatment.   
2. Allow overnight to attach.  Observe under light microscope to ensure all cells are 
attached and not over confluent. 
3. Remove media, either by aspiration or inverting the plate.  Treat cells with 
500µl/well of 3nM treatment media or control media, 10% FBS for treatment and 
control.   
4. Incubate at room temperature overnight. 
5. Remove media, either by aspiration or inverting the plate.  Dissociate cells using 
250µL trypLE.  Once all cells are detached add 1mL media and transfer mixture 
to 1.5mL Eppendorf tube. 
6. Pellet cells by centrifugation at 1400xg for 5min.  Carefully remove supernatant. 
7. Add 100µL reconstituted Steady-Glo luciferase substrate to each tube.  Steady-
Glo substrate is very bubbly so take extra care not to introduce bubbles.   
Resuspend pellet and break up clumps by pipetting up and down gently. 
8. Incubate tubes in the dark for ~40min. 
9. Plate 90µL of each sample/substrate into wells of a 96-well plate.  90µL accounts 
for loss of volume due to bubbles.  
10. Read using BioTek Synergy HT plate reader programmed for luminescence.  A 
plug is used in place of a filter.      
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B4 Antiviral assay 
Used to characterize antiviral activity of a molecule of interest.  Concentration of 
treatment was optimized for dsRNA.        
 
1. Plate 3x104 RTG-2 cells/well into appropriate number of wells in 96-well plate.  
6-wells for each treatment, 6-wells for an infected control, and 6-wells for an 
uninfected control.  
2. Allow overnight to attach.  Observe under light microscope to ensure all cells are 
attached and not over confluent. 
3. Remove media, either by aspiration or inverting the plate.  Add 50µl 3nM 
treatment or control media to each well, use media with 10% FBS for treatment 
and control.  
4. Incubate at room temperature for 24h.  Check cells after incubation to ensure they 
are still attached and have not come off at any point in the treatment.   
5. Remove media, either by aspiration or inverting the plate.  Infect all wells except 
uninfected control with 70µl of a 10-1 dilution of VHSV in 1% FBS media.  Add 
1% FBS media without virus to the control.   
6. Incubate at 17oC for 7-days.  Monitor for cytopathic effects.  If significant cell 
death is not observed in untreated infected control consider extending incubation 
period.   
7. Measure cell viability using CFDA-AM.   
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B5 CFDA-AM cell viability assay  
Used to measure cell viability as an endpoint for many different experiments.  Can be 
scaled up from 96-well plate.  CFDA-AM is a light sensitive.    
1. Remove media from wells by inverting the plate.  Rinse with 100µl PBS/well.  
2. Make CFDA-AM: 10mL PBS and 10.4µL 4nM CFDA-AM. (Solution mixture is 
for an entire 96-well plate, scale down solution if for fewer wells).   
3. Add 100µl of CFDA-AM solution to each well.  Plate an extra row of solution to 
use as a blank.   
4. Incubate the plate in the dark for 1h.  
5. Using the BioTek Synergy HT plate reader and Gen 5 1.11 software read the plate 
at Ex485 Em530. 
 
 
 
 
 
 
 
